Tag: review

  • Role of Alternative Medical Systems in Adult Chronic Kidney Disease Patients: A Systematic Review of Literature

    Role of Alternative Medical Systems in Adult Chronic Kidney Disease Patients: A Systematic Review of Literature

    Chronic kidney disease (CKD) is one of the leading causes of death globally, which affects 13.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of the world’s population [1]. With deterioration in renal function, this leads to the onset of CKD-related complications, such as uremia, anemia, and electrolyte disorders [2]. These complications often manifest as symptoms ranging from pruritus, pain, and insomnia to muscle cramps. This in turn has negative implications on patients’ quality of life [3,4]. Importantly as CKD patients approach end-stage renal disease (ESRD), the prevalence and severity of such symptoms increase [5].

    Despite medical breakthroughs and the advent of new therapies in the past decades, optimal treatments for some of the symptoms resulting from CKD-related complications remained unclear, possibly due to their complex pathophysiology. A case in point is uremic pruritus, which is found in around 20{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of pre-dialysis CKD patients and 40{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of ESRD patients [6]. Although prevalent treatments include the use of emollients, gabapentin, and antihistamines, data related to their efficacy were often derived from small studies and their use is limited by adverse effects [7].

    The use of alternative medical systems (AMS) which forms a key pillar of complementary and alternative medicine (CAM) has increased in the past 20 years [8]. AMS is defined as “entire systems of health theory and practice that developed separately from conventional medicine” [9]. Notably, around 18{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of dialysis patients have utilized some form of AMS [10,11]. In addition, prescription of AMS therapies such as traditional Chinese medicine (TCM) by professional practitioners often aids in minimizing the risk of side effects, hence increasing their appeal as potential therapeutic alternatives [11].

    Prior studies have shown that AMS is effective in reducing symptoms such as pain, nausea, and fatigue in non-CKD patient populations. For instance the use of TCM formulas, such as Liu Junzi Tang and Xiao Banxia Plus Fuling have demonstrated efficacy in treating cancer-related pain and chemotherapy-related nausea and vomiting [12]. In addition, Chinese herbs such as Curcuma longa and Panax ginseng among patients with malignancies have shown efficacy in promoting apoptosis of cancer cells and inhibiting tumor metastasis [13]. Another study showed that a multi-modal Ayurvedic treatment approach was effective in reducing knee osteoarthritis symptoms, such as pain and stiffness, and improving function [14]. With increasing research supporting the use of AMS, this has led to a rise in healthcare institutions adopting and providing such integrated services which are supported by insurance coverage [15].

    Among CKD patients, multiple studies have also been conducted to assess the efficacy of AMS in the treatment of CKD-related conditions and symptoms such as uremic pruritis and anemia. For instance, a study that assessed the efficacy of homeopathy verum among CKD patients showed a reduction in pruritus symptoms by 49{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} after 30 days of treatment [16]. Another study that evaluated the use of TCM patients with glomerulonephritis showed improvement in hemoglobin after 24 weeks of therapy [16,17].

    Existing reviews which have assessed the role of AMS are currently limited to specific indications, such as uremic pruritus [18], use of subtypes of AMS in specific CKD subgroups, such as consumption of Chinese herbal medicine in diabetic kidney disease [19], and specific AMS therapies, such as use of Astragalus [20,21]. This review aimed to summarize and evaluate the broad roles and efficacy of AMS as potential alternative therapeutic options for CKD patients. Findings from the review will aid physicians in gaining a better understanding of the efficacy of AMS for CKD patients, which can aid in facilitating purposeful discussions with patients who are using or considering these therapies.

    Methods

    Protocol and Registration

    The protocol for this study was registered on Open Science Framework (https://osf.io/ymks8/) and was composed based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement and Synthesis without Meta-Analysis (SWiM) reporting guidelines [22,23].

    Information Sources and Search

    A literature search was conducted in MEDLINE, Embase, Scopus, CENTRAL, CINAHL, and PsycINFO. There was no start date restriction, and studies up to April 2022 were included. Key terms related to CKD, randomized controlled trials (RCT), and AMS were included in the searches. The search terms were adapted from other systematic reviews and the full search strategy is available in Appendix 1 [18,24-26].

    Eligibility Criteria

    With regards to inclusion criteria, full-text articles in English language which involved RCTs evaluating the use of AMS in adult CKD patients (>18 years old) were included. As defined by the National Center for Complementary and Integrative Health (NCCIH), AMS is a broad category encompassing a variety of medical modalities and refers to an entire system of theory and practice which developed separately from conventional medicine [15]. In this review, we included TCM, naturopathy, homeopathy, and ayurvedic medicine. Non-RCTs, case series, other systematic reviews, and meta-analyses were excluded.

    Description of Main Types of AMS

    TCM: TCM is a system of medical practice which originated in China and adopts a holistic approach to the medical treatment of a patient based on “syndrome differentiation.” It focuses on the integrity of the human body by emphasizing the intimate relationship between the body and its social and natural environment, as well as dynamic balance of movement [27]. The basic tenet of TCM is based on the flow and balance of vital energy, Qi, which flows through channels in the body called meridians that connect various organs and tissues [28]. Diseases are believed to be brought about by the imbalance of Qi. Hence, by restoring balance via acupoints or intake of herbs, TCM seeks to promote individual wellness and prevent diseases [29].

    Naturopathy: Naturopathy is a form of medical practice which is rooted in vitalism and folk medicine and, promotes natural and self-healing ideologies [30]. The unique attribute of naturopathic medicine lies in the reprioritization of the order of therapeutics with increased emphasis on preventive behaviors, lifestyle modifications, nutrition, and exercise, over medical or surgical interventions [31].

    Homeopathy: Homeopathy entails the therapeutic administration of substances derived from plants, minerals, or animals that produce effects that correspond to the clinical manifestation of diseases [32]. Its practice is centered on two following theories: “like cures like” and “law of minimum dose.” “Like cures like” refers to the belief that diseases can be treated with substances that produce similar symptoms in healthy individuals, and “law of minimum dose” refers to the belief that the lower the dose the greater its therapeutic efficacy [32].

    Ayurvedic medicine: Ayurvedic medicine is one of the oldest alternative medical systems which involves the use of therapeutics derived predominantly from plants, animals, minerals, diet, exercise, and lifestyle changes. Its therapies are centered on the principle of “Panchakarma,” which comprises five karmas (actions) to rejuvenate and remove toxins from one’s body [33].

    Study Selection and Data Collection Process

    Citations retrieved from the six databases were extracted into Endnote X9 software (Philadelphia, PA: Clarivate) and duplicated citations were removed. During the initial article screening, two independent reviewers (WY and SW) reviewed the titles and abstracts of articles to select relevant articles. Thereafter, the full texts of the identified articles were evaluated. All discrepancies during the article screening process were resolved by discussion with a third reviewer (JJ). Hand-searching of references within identified articles was also performed to enhance the comprehensiveness of the search. A standardized Microsoft Excel data collection form was used for data extraction, and details related to the study characteristics, studied indications of intervention, efficacy, and safety were collected.

    Management of Missing Data

    For studies with missing data, authors were contacted for clarification to enhance the comprehensiveness of this review. Missing information that could not be retrieved after two email reminders were labeled as unavailable.

    Risk of Bias in Individual Studies

    The Cochrane Risk of Bias tool version 2.0 (Oxford, England: Cochrane) was utilized in the assessment of the included RCTs [34]. Two independent reviewers (Teo and Chu) performed the risk of bias assessment (Appendix 2). The instrument comprises of the following five domains: risk of bias arising from the randomization process, deviations from intended interventions, missing outcome data, outcome measurement, and selection of reported results. Using the responses derived from the five domains, the overall risk of bias for the individual studies was rated as “low,” “some concerns,” or “high” risk of bias.

    Assessment of Heterogeneity

    Clinical and methodological heterogeneity of included studies were analyzed to evaluate if meta-analyses could be performed for specific interventions in this study. Clinical heterogeneity describes variation in characteristics of study participants, intervention, or outcomes while methodological heterogeneity describes variation in study design and risk of bias. This was performed by two independent reviewers (Yeam and Seng). In view of the clinical and methodological heterogeneity across the included studies, a narrative review of the RCTs was conducted.

    Synthesis of Data

    With regard to the efficacy of AMS interventions, the response rates and any changes in patients’ quality of life were recorded. Additionally, the safety profile of each intervention was evaluated and the reported prevalence, severity, and outcomes of adverse effects were tabulated. The adverse events reported in included studies were categorized using the Common Terminology Criteria for Adverse Events (CTCAE) [35].

    Summary Measures

    Descriptive statistics were utilized to summarize the characteristics of all included studies. The principal summary measures evaluated in this study were the studied indications, efficacy of each AMS, and safety profile of each AMS.

    Results

    Study Selection

    Out of 14,583 retrieved citations, 33 full-text articles were included in this review. The inclusion and exclusion criteria for the studies are shown in Figure 1. The percentage of agreement of articles between the reviewers was 94.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} and all disagreements were resolved after discussion.

    Study Characteristics

    Types of AMS studied: Table 1 shows the characteristics of included studies. Among the four main types of AMS, TCM was the most studied (n=20, 60.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [3,7,17,36-52], followed by Ayurveda (n=6, 18.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [53-58], naturopathy (n=5, 15.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [59-63], and homeopathy (n=2, 6.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [16,64].

    Study (year of publication) Study design Number of patients in treatment and control arm Indication for use of intervention Treatment Comparator Country Patient population Mean age of patients (SD) Gender (male) ({fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c})
    Traditional Chinese medicine (n=20)
    Li et al. (2015) [41] Double-blinded parallel arm T1:66, C1:32, T2:56, C2:26 Renal function 8 g TSF granules and ARB BID x 24 weeks 8 g placebo TID and ARB BID x 24 weeks China Non-dialysis CKD patients T1:59.5 (10.1), C1:56.7 (9.3), T2:58.9 (9.0), C2:60.8 (10.0) T1:54.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C1:53.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, T2:58.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C2:53.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Ma et al. (2013) [43] Parallel arm T:25, C:20 Renal function 150 mL ZSTL solution BID x 3 months 10 mg benazepril QD x 3 months China Early DN patients T:57, C:57 T:40{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:40{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Wang et al. (2012) [17] Double-blinded parallel arm T1:192, T2:191, C:189 Renal function T1: TCM granules BID x 24 weeks, T2: TCM granules BID and 10mg benazepril QD x 24 weeks 10 mg benazepril QD and TCM placebo TID x 24 weeks China CKD stage 3 T1:47.3 (10.9), T2:49.3 (11.4), C:49.0 (10.5) T1:54.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, T2:47.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:47.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Yu et al. (2017) [50] Single-blinded parallel arm T:28, C:25 Renal function Acupuncture at Li4, ST36 and K13 acupoint QD x 3 months Sham acupuncture QD x 3 months China CKD stage 2-4 T:58.5, C:61.0 T:89.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:88.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Zhao et al. (2020) [52] Double-blinded parallel arm T:171, C:172 Renal function Herbal granules TID x 6 months Placebo granules x TID 6 months China CKD stage 3 T:51.89 (13.12), C:52.03 (12.62) T:62.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:70.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Xiang et al. (2016) [47] Parallel arm T:51, C:51 Renal function QDDHGa tablets BID x 12 weeks ARB tablets (minimum dosage) China DN patients T:57.21 (13.20), C:58.16 (11.59) T:24{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:22{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Xu et al. (2016) [49] Double-blinded parallel arm T:91, C:86 Renal function 500 mg GS-Rb1 (ginseng extract) QD x 6 months  Placebo tablets QD x 6 months China CKD stage 2-3 T:59.2 (8.5), C:58.4 (7.5) T:72.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:70.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Chen et al. (2013) [37] Parallel arm T:95, C:95 Proteinuria 9.6 g of Shenqi particle TID x 48 weeks Routine care China Non-dialysis CKD patients T:49 (14), C:53 (12) T:36.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:68.42{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Ge et al. (2013) [39] Parallel arm T:34, C:31 Proteinuria  40 mg TWHF TID x 3 months followed by 20 mg TWHF TID x 3 months 80 mg valsartan BID x 6 months China DN patients T:51.9 (9.8), C:51.0 (8.9) T:58.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:54.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Li et al. (2020) [42] Double-blinded parallel arm T:735, C:735 Proteinuria Huangkui capsule TID x 12 months Losartan potassium tablet QD and placebo capsules TIW x 12 months China CKD stage 1-3a T:37.7 (10.9), C:37.1 (10.4) T:48.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:46.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Zhang et al. (2014) [51] Parallel arm T1:133, T2:136, C:135 Proteinuria T1: Huangkui capsule TID x 6 months, T2: Huangkui capsule TID and Losartan potassium tablet QD x 6 months  Losartan tablet potassium QD x 6 months  China Non-dialysis CKD patients T1:37.3 (12.5), T2:37.1 (11.1), C:38.1 (12.7) T1:50.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, T2:47.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:53.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Xiong et al. (2020) [48] Parallel arm T:62, C:62 Proteinuria 60 mg TWHF and 160 mg valsartan QD x 24 weeks 160 valsartan QD x 24 weeks China Non-dialysis CKD patients T:50.3 (11.8), C:49.6 (12.3) T:69.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:72.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Che-Yi et al. (2005) [36] Double-blinded parallel arm T:20, C:20 Uremic pruritus Acupuncture at Quchi (L11) acupoint TIW x 1 month Sham acupuncture TIW x 1 month China ESRD T:62.4 (9.1), C:63.2 (7.5) T:45.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:50.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Gao et al. (2002) [38] Double-blinded parallel arm T:34, C:34 Uremic pruritus Acupuncture at Quchi (L11) and Zusanli (ST 36) acupoint BIW x 1 month Sham acupuncture BIW x 1 month China ESRD 43.6 59.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Nahidi et al. (2018) [7] Single-blinded parallel arm T:15, C:11 Uremic pruritus Acupuncture at various acupoints TIW x 6 weeks Sham acupuncture TIW x 6 weeks Iran HD T:54.7 (11.4), C:41.4 (16.2) T:60{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:73{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Ono et al. (2015) [3] Parallel arm T:23, C:17 Fatigue, insomnia, itchiness, and pain Acupuncture QIW x 2 months Routine care Japan HD T:70.0 (9.6), C:67.3 (13.0) NI
    Su et al. (2009) [44] Parallel arm T:31, C:30 QoL Infrared stimulation of Qihai (RN6), Kuamyuan (RN4) and Chungchi (RN3) TIW x 3 months Heat pad therapy to acupoints TIW x 3 months China ESRD T:61.07 (13.9), C:58.6 (12.6) T:51.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:56.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Wang et al. (2019) [45] Single-blinded parallel arm T:40, C:40 Wnt/β-catenin signaling pathway Qingshen granules TID x 3 months Placebo granules TID x 3 months China CKD stage 3-5 T:52.1 (10.4), C:54.9 (9.2) T:55{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:48{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Wang et al. (2020) [46] Parallel arm T:136, C:146 Immune function Qingshen granules TID x 3 months Routine care China CKD stage 3-5 T:54.0 (10.5), C:51.8 (12.0) T:55.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:57.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Li et al. (2009) [40] Parallel arm T:32, C:32 Vascular endothelial function TBN tablets (gingko extract) TI x 8 weeks Routine care China Early DN patients T:66.5 (71.1), C:67.2 (7.2) T:53.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:50{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Ayurveda (n=6)
    Alam et al. (2020) [53] Parallel arm T:70, C:66 Renal function Sativa oil QD and alpha-keto amino acid tablets TID x 3 months Alpha-keto amino acid tablets TID x 3 months India CKD stage 3-4 T:49.2, C:48.8 T:58.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:51.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Fallahzadeh et al. (2012) [54] Double-blinded parallel arm T:30, C:30 Renal function 140 mg silymarin tablet QD x 3 months Placebo tablet QD x 3 months Iran Non-dialysis CKD patients T:55.9 (8.3), C:57.6 (7.5) T:50{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:43.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Hoseini et al. (2019) [55] Parallel arm T:22, C:22 Renal function Camel milk BID x 3 months Routine care Iran CKD stage 3-4 56.7 (11.8) 52.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Khajehdehi et al. (2011) [56] Double-blinded parallel arm T:28, C:28 Renal function 140 mg silymarin TID x 3 months Placebo tablet TID x 3 months Iran Non-dialysis CKD patients T:55.9 (8.3), C:57.6 (7.5) T:50{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:43.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Makhlough et al. (2010) [57] Double-blinded parallel arm T:17, C:17 Uremic pruritus 0.03{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} capsaicin ointment QID x 4 weeks Placebo ointment QID x 4 weeks Iran ESRD 57 (18.6) 41.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Pingali et al. (2020) [58] Double-blinded parallel arm T1:18, T2:18, C:19 Hyperuricemia T1:500 mg of beleric capsule taken QD T2: 1000 mg of beleric capsule taken QD C:40 mg of febuxostat taken QD India CKD stage 2-3 T1:53.2 (8.9), T2:50.8 (8.8), C:51.0 (9.8) T1:72.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, T2:77.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:73.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Naturopathy (n=5)
    Khan et al. (2014) [60] Double-blinded parallel arm T:80, C:80 Malnutrition  Alpha-keto amino acid tablets TID x 3 months Placebo tablets TID x 3 months India Non-dialysis CKD patients T:45.0, C:45.0 T:59.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:57.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Prakash et al. (2004) [61] Double-blinded parallel arm T:21, C:19 Malnutrition  Keto amino acid tablets QD x 9 months Placebo tablets QD x 9 months India CKD stage 3-4 T:52.8 (14.1), C:55.9 (17.6) T:55.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:43.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Sedaghattalab et al. (2021) [62] Double-blinded parallel arm T:22, C:23 Inflammation Watercress extract QD x 1 month Placebo extract QD x 1 month Iran HD T:58.9 (16), C:63.1 (13) NI
    Zare et al. (2019) [63] Double-blinded parallel arm T:19, C:21 Inflammation Garlic extract tablets TIW x 2 months Placebo tablets TIW x 2 months Iran PD T:56.0 (16.1), C:52.8 (18.8) T:42.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:42.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Boldaji et al. (2019) [59] Crossover trial T:22, C:19 Hypertension, stress, and inflammation Pomegranate juice TIW x 2 months Routine care Iran ESRD 47.8 (13.3) 61{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Homeopathy (n=2)
    Cavalcanti et al. (2003) [16] Double-blinded parallel arm T:11, C:9 Uremic pruritus Homeopathic verum medicationb administered Placebo medication administered Brazil HD T:47, C:57 T:64{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:56{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Silveira et al. (2019) [64] Double-blinded parallel arm T:18, C:14 Renal function Brazilian green propolis pills BID x 3 months Placebo pills BID x 3 months Brazil CKD stage 1-5 T:52.8 (14.1), C:55.9 (17.6) T:55.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:43.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}

    Overview of study design and patient characteristics in included studies are as follows: the majority of the studies were conducted in Asia (n=31, 93.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), whereas most of the studies were performed in China (n=18, 54.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}). Out of all reviewed studies, 20 (60.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) were blinded to randomized controlled trials. The sample size was greater than 50 patients in 21 (63.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) trials (Table 1). Non-dialysis patients were recruited in seven studies (21.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), whereas ESRD patients were recruited in five studies (15.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}). The average duration of follow-up for all studies was 4.9 months (Table 2).

    Study (year of publication) Indication for use of intervention Treatment (dose and duration if available) Comparator (dose and duration if available) Tool(s) used to assess outcomes Outcome Improvement symptoms (yes / no) Percentage reductiona/improvement in symptoms (if available) Follow-up duration
    Traditional Chinese medicine (n=20)
    Li et al. (2015) [41] Renal function 8 g TSF granules TID and ARB BID x 24 weeks 8 g placebo TID and ARB BID x 24 weeks WHOQOL-BREF, DQOL UAER (μg/min) (pre vs post): 105.39±77.29 vs 88.37±108.46, p=0.021 Yes -16.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (UAER) 6 months
    24 h urinary protein (g/24 h) (pre vs post): 1.12±0.75 vs 0.91±0.90, p=0.017 -18.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (24 h urinary protein)
    Ma et al. (2013) [43] Renal function 150 mL ZSTL solution BID x 3 months 10 mg benazepril QD x 3 months Radioimmunoassay, ELISA HbA1c ({fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) (baseline vs mean change from baseline): 10.68 (8.48, 13.96) vs -4.29 (-5.85, -2.79), p<0.05. Yes -40.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (HbA1c) 9 months
    UAER (μg/min) (baseline vs mean change from baseline): 211.52 (164.58, 243.89) vs -106.99 (-121.29, -85.55), p<0.05 -50.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (UAER)
    SCr (μmol/L) (baseline vs mean change from baseline): 87.17 (70.59, 110.25) vs -3.33 (-11.02, 2.15), p<0.05 -3.82{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (SCr)
    CCR (mL/min) (baseline vs mean change from baseline): 139.86 (129.58, 149.52) vs -9.22 (-13.42, -5.82), p <0.05 -6.59{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (CCR)
    Wang et al. (2012) [17] Renal function T1: TCM granuleb BID x 24 weeks. T2: TCM granuleb BID and 10 mg benazepril QD x 24 weeks. 10 mg benazepril QD and TCM placebo TID x 24 weeks MDRD study equation, TCM assessing sheets eGFR (mL/min/1.73 m2) (pre vs post): T1: 45.26±10.12 vs 48.46±15.90, p<0.05. T2: 44.68±9.82 vs 48.31±17.50, p<0.05. Yes 7.07{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (eGFR; T1), 8.12{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (eGFR; T2) 6 months
    24 h proteinuria (mg/24 h) (pre vs post): T1: 725.98 vs 990.00, p<0.05. T2: 590.00 vs 453.50, p<0.05 36.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (proteinuria; T1), -21.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (proteinuria; T2)
    Urinary albumin/creatinine (mg/gCr) (pre vs post): T2: 0.30 vs 0.22, p<0.05 -26.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (urinary albumin/creatinine; T2)
    Hb (g/L) (pre vs post): T1: 127.31±18.47 vs 129.57±21.82, p<0.05 17.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (Hb; T1)
    Yu et al. (2017) [50] Renal function Acupuncture at Li4, ST36 and K13 acupoint QD x 3 months Sham acupuncture QD x 3 months NI SCr levels (mg/dL) (T vs C): baseline: 1.45 vs 1.67, p=0.1298. Post-intervention: 1.41 vs 1.65, p=0.0489. 3-month follow-up: 1.32 vs 1.81, p=0.0467 Yes -2.76{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (SCr; pre vs post), -9.00{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (SCr; pre- vs 3 months follow-up) 6 months
    eGFR (mL/min/1.73m2) (T vs C): Baseline: 51.85 vs 42.50, p=0.0855. Post-intervention: 54.50 vs 43.60, p=0.0470. 3-month follow-up: 59.90 vs 40.80, p=0.0191 5.11{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (eGFR; pre vs post), 15.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (eGFR; pre-intervention vs 3 months follow-up)
    hs-CRP (mg/dL) (T vs C): Baseline: 1.10 vs 0.79, p=0.4361. Post-intervention: 0.80 vs 0.90, p=0.8773 -27.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (hs-CRP pre vs post)
    Zhao et al. (2020) [52] Renal function Herbal granulec TID x 6 months Placebo granules x TID 6 months Dye-binding method, Cerebrospinal fluid protein test kit, Determiner L CRE kit SCr (μmol/L) (pre vs weeks 16, 20 and 24): 148.42±35.90 vs 130.19±29.79, 130.08±30.57, 130.78±32.55, p<0.05 Yes -12.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (SCr; pre vs 16 weeks), -12.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (SCr; pre vs 20 weeks), -11.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (SCr; pre vs 24 weeks) 6 months
    Xiang et al. (2016) [47] Renal function QDDHG tablets BID and ARB (minimum dosage) x 12 weeks ARB tablets (minimum dosage) Guidelines for clinical research of Chinese medicine Albumin (mg/24h) (within treatment group, baseline vs 4 vs 8 vs 12 week): 85.30 (66.00, 176.30) vs 61.50 (49.00, 110.20), p<0.05 vs 51.00 (37.00, 90.00), p<0.05 vs 41.40 (29.00, 68.00), p<0.05 Yes -27.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (Albumin; 4 weeks), -40.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (Albumin; 8 weeks), -43.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (Albumin; 12 weeks) 3 months
    Proteinuria (g/24h) (within treatment group, baseline vs 4 vs 8 vs 12 week): 0.20 (0.10, 0.30) vs 0.10 (0.10, 0.20), p<0.05 vs 0.10 (0.10, 0.20), p<0.05 vs 0.10 (0.10, 0.20), p<0.05 -50{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (Proteinuria; 4, 8, 12 weeks)
    Albumin/creatinine (mg/mol) (within treatment group, baseline vs 4 vs 8 vs 12 week): 20.70 (11.00, 30.50) vs 16.30 (8.10, 25.00), p<0.05 vs 15.00 (7.20, 20.60), p<0.05 vs 10.10 (5.60, 17.00), p<0.05 -21.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (albumin/creatinine; 4 weeks), -27.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (albumin/creatinine; 8 weeks), -51.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (albumin/creatinine; 12 weeks)
    Xu et al. (2016) [49] Renal function 500 mg GS-Rb1 (ginseng extract) QD x 6 months  Placebo tablets QD x 6 months ELISA Creatinine and urea level (T vs C): 6 months, p<0.01. 12 months, p<0.01 Yes 12 months
    Oxidative stress markers (T vs C): 6 months, p<0.01. 12 months, p<0.05
    TNF-a level (T vs C): 6 months, p<0.05
    Chen et al. (2013) [37] Proteinuria 9.6 g of Shenqi particle TID x 48 weeks Routine care MDRD study equation Proteinuria (g/d) (pre vs post): 5.34±2.74 vs 2.04±2.15, p<0.001 Yes -61.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (proteinuria) 12 months
    eGFR (mL/min/1.73 m2) (pre vs post): 84.6±27.0 vs 100.7±37.5, p=0.001 19.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (eGFR)
    Ge et al. (2013) [39] Proteinuria 40 mg TwHF TID x 3 months, 20 mg TwHF TID x 3 months. 160 mg valsartan capsules QD x 6 months Trichloroacetic acid method, Jaffe reaction, MDRD study equation, high-performance liquid chromatography Urinary protein (g/24 h) (pre vs 1 month, pre vs 3 months, pre vs 6 months): 4.99±2.25 vs 3.23±2.57, p<0.01. 4.99±2.25 vs 2.83±1.57, p<0.01. 4.99±2.25 vs 2.99±1.81, p<0.01 Yes -35.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (urinary protein; 1 months), -43.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (urinary protein; 3 months), -40.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (urinary protein; 6 months) 6 months
    eGFR (mL/min/1.73 m2) (pre vs 6 months): 43.07±21.65 vs 38.71±23.66, p<0.05 -10.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (eGFR; 6 months)
    Li et al. (2020) [42] Proteinuria Huangkui capsule TID x 12 months Losartan potassium tablet QD and placebo capsules TIW x 12 months NI Proteinuria (mg/24 h) (pre vs post): 1238.9±667.4 vs 1008.8±1104.7, p<0.001 Yes -18.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (proteinuria) 12 months
    Zhang et al. (2014) [51] Proteinuria T1: Huangkui capsule TID x 6 months. T2: Huangkui capsule TID and Losartan potassium tablet QD x 6 months. Losartan tablet potassium QD x 6 months Biuret method, sarcosine oxidase assay Proteinuria within T1 (pre vs 12 vs 24 weeks): 1045±420 vs 762±533, p<0.001 vs 537±409, p<0.001 Yes T1: -27.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pre vs 12 weeks), -48.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pre vs 24 weeks) 6 months
    Proteinuria within T2 (pre vs 12 vs 24 weeks): 1073±439 vs 783±658, p<0.001 vs 529±509, p<0.001. T2: -27.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pre vs 12 weeks), -50.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pre vs 24 weeks).
    Xiong et al. (2020) [48] Proteinuria 60 mg TWHF and 160 mg valsartan QD x 24 weeks 160 valsartan QD x 24 weeks CKD-EPI equation Proteinuria (g/24 h) (T vs C, PP analysis): 3.16±0.62 vs 4.28±0.85, p<0.001 Yes PP: -26.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (proteinuria)  6 months
    Serum albumin (g/L) (T vs C, PP analysis): 37.65±4.31 vs 33.59±4.56, p<0.001 PP: 12.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (serum albumin)
    Proteinuria (g/24 h) (T vs C, ITT analysis): 3.36±0.83 vs 4.52±1.06; p<0.001 ITT: -25.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (proteinuria)
    Serum albumin (g/L) (T vs C, ITT analysis): 36.91±4.42 vs 34.67±4.75, p=0.008 ITT: 6.46{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (serum albumin)
    Che-yi et al. (2005) [36] Uremic pruritus Acupuncture at Quchi (L11) acupoint TIW x 1 month Sham acupuncture TIW x 1 month Validated questionnaire Pruritus scores (pre vs post vs 3 months follow-up): 38.2±4.8 vs 17.3±5.5 vs 16.5±4.9, p<0.001 Yes -54.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pruritus scores; pre- vs post-intervention), -56.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pruritus scores; pre-intervention vs 3 months follow-up) 3 months
    Gao et al. (2002) [38] Uremic pruritus Acupuncture at Quchi (L11) and Zusanli (ST 36) acupoint BIW x 1 month Sham acupuncture BIW x 1 month NI Number of patients (complete alleviation vs improvement vs no effect): 24 (70.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) vs 9 (26.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) vs 1 (2.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) Yes 3 months
    Nahidi et al. (2018) [7] Uremic pruritus 30 minutes of acupuncture, for six weeks, at the following acupoints: Sp6, Sp10, Lv3, Li4, Li11. 30 minutes of sham acupuncture, for 6 weeks. VAS Pruritus scores (pre vs post): 9.87±0.35 vs 3.93±2.85, p<0.001 Yes -60.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pruritus scores) 6 weeks
    Ono et al. (2015) [3] Fatigue, insomnia, itchiness, and pain Acupuncture QIW x 2 months Routine care VAS, EQ-5D Headache score (pre vs post): 17.1±26.1 vs 6.2±13.5, p<0.05. Yes -63.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (headache score)  3 months
    Blurred vision score (pre vs post): 33.4±32.7 vs 17.0±22.2, p<0.05. -49.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (blurred vision score) 
    Dizziness score (pre vs post): 13.0±21.4 vs 1.4±6.3, p<0.05. -89.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (dizziness score) 
    Ear buzzing (pre vs post): 17.9±27.2 vs 8.0±14.7, p<0.05 -55.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (ear buzzing)
    Cervical pain (pre vs post): 37.7±39.1 vs 25.3±29.7, p<0.05 -32.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (cervical pain) 
    Stiff shoulders (pre vs post): 29.9±28.6 vs 12.5±21.6, p<0.05 -58.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (stiff shoulders) 
    Back pain (pre vs post): 38.5±33.7 vs 9.3±18.1, p<0.05 -58.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (back pain)
    Lower limb pain (pre vs post): 29.4±36.4 vs 17.1±23.3, p<0.05 -41.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (lower limb pain) 
    Numbness in upper limb (pre vs post): 18.9±30.4 vs 4.0±29.5, p<0.05 -78.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (numbness in upper limb) 
    Numbness in lower limb (pre vs post): 21.9±34.9 vs 11.0±26.2, p<0.05 -49.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (numbness in lower limb) 
    Itchiness (pre vs post): 38.7±40.7 vs 29.3±31.5, p<0.05 -24.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (itchiness)
    Difficulty in sleeping (pre vs post): 34.8±36.9 vs 12.8±22.5, p<0.05 -63.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (difficulty in sleeping)
    Utility in treatment group (pre vs post): 0.66±0.15 vs 0.76±0.17, p<0.05 15.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (utility)
    Su et al. (2009) [44] QoL Infrared stimulation of Qihai (RN6), Kuamyuan (RN4) and Chungchi (RN3) TIW x 3 months Heat pad therapy to acupoints TIW x 3 months Heart rate variability analyser, WHOQOL-BREF questionnaire LF activity (pre vs post): 49.99±79.08 vs 131.71±214.36, p=0.01 Yes 163{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (LF activity) 3 months
    Fatigue index (pre vs post): 133.90±20.43 vs 121.71±32.68, p=0.02 -9.10{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (fatigue index)
    Psychological domain (pre vs post): 18.16±4.30 vs 19.39±0.72, p=0.02 6.77{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (psychological domain)
    Environmental domain (pre vs post): 29.87±4.04 vs 32.00±4.85, p=0.00. 7.13{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (environmental)
    Wang et al. (2019) [45] Wnt/β-catenin signaling pathway Qingshen granules TID x 3 months Placebo granules TID x 3 months ELISA Effective rates of TCM symptom (T vs C): 80{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} vs 60{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, p=0.024 Yes 3 months
    eGFR (mL/min) (T vs C): 15.9±3.2 vs 14.0±4.0, p=0.019 17.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (eGFR)
    HIF-1𝛼 (ng/mL) (T vs C): 0.66±0.16 vs 1.39±0.17, p≤0.001 -61.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (HIF-1𝛼)
    Wnt1 (pg/mL) (T vs C): 314.2±85.8 vs 382.8±85.3, p=0.001 -16.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (Wnt1)
    𝛽-catenin (pg/mL) (T vs C): 416.5±13.6 vs 462.1±15.1, p ≤0.001 -10.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (𝛽-catenin)
    𝛼-SMA (KU/L) (T vs C): 20.5±3.1 vs 23.5±4.1, p≤0.001 -20.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (𝛼-SMA)
    E-cadherin (ng/mL) (T vs C): 2166.9±398.6 vs 2370.7±468.0, p=0.039 -15.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (E-cadherin)
    Wang et al. (2020) [46] Immune function Qingshen granules TID x 3 months Routine care Flow cytometry, ELISA CD4+/CD8+ T cell (pre vs post): 1.98±0.86 vs 1.58±0.72, p<0.05. Yes -20.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (CD4+/CD8+ T cell) 3 months
    Th17 cell (pre vs post): 2.51±1.05 vs 1.70±0.83, p<0.01. -32.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (Th17)
    NF-κB p65 (pre vs post): 36.84±12.96 vs 24.86±1.97, p<0.05 -32.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (NF-κB p65)
    IL-17 (pre vs post): 28.62±13.53 vs 19.78±12.25, p<0.05 -30.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (IL-17)
    IL-6 (pre vs post): 77.13±20.54 vs 58.42±18.25, p<0.05 -24.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (IL-6)
    TNF-α (pre vs post): 110.34±23.76 vs 75.49±22.80, p<0.01 -31.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (TNF-α)
    TRAF6 (pre vs post): 4.94±1.82 vs 2.85±1.53, p<0.01 -42.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (TRAF6)
    FN (pre vs post): 93.42±20.36 vs 62.86±19.35, p<0.01 -32.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (FN)
    Col-IV (pre vs post): 36.85±14.58 vs 24.36±13.36, p<0.01 -33.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (Col-IV)
    Total effective rate (T vs C): 79.41{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} vs 67.12{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, p<0.05.
    Li et al. (2009) [40] Vascular endothelial function TBN tablets (gingko extract) TID x 8 weeks Routine care Chemical colorimeter, Radioimmunoassay, ELISA, Siemens Sequoia 512 color Doppler ultrasonography UAER (μg/min) (pre vs post): 153.30±63.28 vs 85.15±36.82, p<0.01 Yes -44.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (UAER) 3 months
    SCr (μmol/L) (pre vs post): 120.76±17.83 vs 105.67±18.13, p<0.01 -12.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (SCr)
    NO (μmol/L) (pre vs post): 50.16±24.64 vs 70.65±28.71, p<0.01 40.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (NO)
    vWF ({fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) (pre vs post): 182.05±64.13 vs 128.56±48.98, p<0.01 -29.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (vWF)
    BAID responsive change ({fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) (pre vs post): 4.91±2.31 vs 6.78±3.89, p<0.01 38.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (BAID responsive change)
    Ayurveda (n=6)
    Alam et al. (2020) [53] Renal function Sativa oil QD and alpha-keto amino acid tablets TID x 3 months Alpha-keto amino acid tablets TID x 3 months Hemogram, renal function test, serum electrolyte test Hb{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (g/dL) (pre vs post): 8.84±1.31 vs 10.24±1.10, p<0.001 Yes 15.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (Hb{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) 3 months
    24-h TUV (mL/day) (pre vs post): 1250.69±303.74 vs 1660.14±258.78, p<0.001 32.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (TUV)
    eGFR (mL/min) (pre vs post): 22.71±7.28 vs 42.42±17.38, p<0.001 86.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (eGFR)
    Fallahzadeh et al. (2012) [54] Renal function 140 mg silymarin tablet QD x 3 months Placebo tablet QD x 3 months Jaffé method, ELISA MDA assay, MDRD study equation, nephelometry, high-performance liquid chromatography, mercury sphygmomanometer Urinary TNF-α (pg/mg) (change from baseline): -3.45 (-5.44 to -1.46), p<0.05 Yes 2 months
    Urinary MDA (nmol/mg) (change from baseline): -1.5 (-2.87 to -0.13, p<0.05
    Serum MDA (μmol/L) (change from baseline): -3.43 (-6.02 to -0.83), p<0.05
    Hoseini et al. (2019) [55] Renal function Camel milk BID x 3 months Routine care MDRD eGFR (pre vs post): 26.9±7.39 vs 31.45±8.99, p=0.001 Yes 16.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (eGFR) 3 months
    SCr levels (pre vs post): 2.58±0.71 vs 2.2±0.48, p=0.01 -14.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (SCr)
    BUN (pre vs post): 60.31±22.61 vs 44.38±14.29, p=0.0001 -26.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (BUN)
    Khajehdehi et al. (2011) [56] Renal function 140 mg silymarin TID x 3 months Placebo tablet TID x 3 months ELISA Proteinuria (mg/24h) (pre vs post, patients with type 2 diabetic nephropathy): 4328.7±3038.2 vs 2354.7±1800.1, p=0.001 Yes -45.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (proteinuria) 2 months
    IL-8 (pg/mL) (pre vs post, patients with type 2 diabetic nephropathy): 99.1±97.9 vs 43.6±55.0, p=0.002 -56.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (IL-8)
    TGF-β (pg/mL) (pre vs post, patients with overt type 2 diabetic nephropathy): 522.3±189.2 vs 397.3±55.2, p=0.006 -23.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (TGB-β)
    IL-8 (pg/mL) (pre vs post, patients with overt type 2 diabetic nephropathy): 41.4±50.3 vs 30.6±75.2, p=0.02 -26.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (IL-8)
    Makhlough et al. (2010) [57] Uremic pruritus 0.03{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} capsaicin ointment QID x 4 weeks Placebo ointment QID x 4 weeks Uremic pruritus scoring questionnaire by Duo Pruritus score (T vs C): 2.5±2.5 vs 7.2±5.5, p<0.05 Yes -84.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pruritus score)  
    Pingali et al. (2020) [58] Hyperuricemia T1:500 mg of beleric capsule taken QD. T2: 1000 mg of beleric capsule taken QD 40 mg of Febuxostat taken QD Jaffe method, MDRD Study equation, Salbutamol challenge test, Ellman’s method, Chrono-log light transmittance aggregometry, Spectrometry, Colorimetric detection with Griess reagents SCr (pre vs post): group B: 1.86±0.32 vs 1.64±0.29, p≤0.005. Group C: 2.06±0.26 vs 1.56±0.24, p≤0.0001 Yes -11.70{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}±9.00 (SCr, group B), -24.42{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}±8.14 (SCr, group C). 6 months
    eGFR (pre vs post): group B: 39.13±6.57 vs 45.96±11.14, p≤0.005. Group C: 34.78±5.34 vs 48.93±11.46, p≤0.0001 16.96{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}±14.87 (eGFR, group B), 40.39{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}±20.98 (eGFR, group C)
    Serum uric acid (pre vs post): Group B:8.10±0.67 vs 6.46±0.34, p≤0.0001. Group C: 8.54±0.64 vs 5.63±0.37, p≤0.0001 19.84{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}±6.43 (serum uric acid, group B), 33.88{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}±4.95 (serum uric acid, group C)
    Naturopathy (n=5)
    Khan et al. (2014) [60] Malnutrition Alpha-keto amino acid tablets TID x 3 months Placebo tablets TID x 3 months Blood tests Hb{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (g/dL) (T vs C): 9.39±0.87 vs 8.91±1.48, p<0.05 Yes 19.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (Hb{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) 3 months
    FBG (mg/dL) (T vs C): 104.00±8.46 vs 113.78±14.31, p<0.001 -20.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (FBG)
    Blood urea (mg/dL) (T vs C): 66.07±19.29 vs 79.78±24.79, p<0.001 -38.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (blood urea)
    SCr (mg/dL) (T vs C): 2.83±1.10 vs 3.33±1.37, p<0.05 -39.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (SCr)
    24 h TUP (g/day) (T vs C): 2.06±0.61 vs 2.43±0.97, p<0.01 -38.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (TUP)
    24 Hour TUV (mL/day) (T vs C): 1943.23±204.1 vs 1736.76±176.04, p<0.001 33.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (TUV)
    GFR (mL/min) (T vs C): 29.4±3.68 vs 23.3±1.63, p<0.001 49.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (GFR)
    Prakash et al. (2004) [61] Malnutrition Keto amino acid tablets QD x 9 months Placebo tablets QD x 9 months 99mTc-DTPA plasma sample method GFR (mL/min/ 1.73 m2) (pre vs post within C): 28.6±17.6 vs 22.5±15.9, p=0.015. Progress of renal failure prevented. 9 months
    Serum total proteins (g{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) (pre vs post within C): 7.04±0.66 vs 6.56±0.83, p=0.038
    Mid-arm circumference (cm) (pre vs post within C): 28.0±4.4 vs 27.3±4.8, p=0.048
    Sedaghattalab et al. (2021) [62] Inflammation Watercress extract QD x 1 month Placebo extract QD x 1 month Blood tests, TBA reaction assay, Colorimetric kits, Spectrophotometer BUN (mg/dL) (pre vs post): 40.6±11.2 vs 34.6±15.1, p<0.04. Yes -14.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (BUN) 1 month
    Calcium (mg/dL) (pre vs post): 8.8±1.32 vs 10.4±2, p<0.001 18.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (calcium)
    Total oxidant status (μM) (pre vs post): 11.3±3.3 vs 6.9±2.4, p<0.001 -38.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (total oxidant status)
    Sulfhydryl protein (mmol/L) (pre vs post): 13.1±5.3 vs 7.4±4.3, p<0.001 -43.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (sulfhydryl protein)
    MDA (mmol/L) (pre vs post): 1.6±0.13 vs 0.42±0.27, p<0.001 -73.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (MDA)
    Superoxide dismutase (U/mL) (pre vs post): 29.3±6.3 vs 37.1±8.4, p<0.001 26.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (superoxide dismutase)
    Zare et al. (2019) [63] Inflammation Garlic extract tablets TIW x 2 months Placebo tablets TIW x 2 months Human homocysteine kits, ELISA IL-6 (pg/mL) (pre vs post): 2.2 (0.8, 6.4) vs 0.7 (0.6, 1.2), p<0.001 Yes -68.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (IL-6) 2 months
    CRP (mg/L) (pre vs post): 13.0 (5.0, 14.0) vs 2.0 (1.0, 9.0), p<0.001 -84.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (CRP)
    ESR (mm) (pre vs post): 50.7±28.5 vs 35.4±21.7, p=0.021. -30.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (ESR)
    Boldaji et al. (2019) [59] Hypertension, stress, and inflammation Pomegranate juice TIW x 2 months Routine care Mini nutritional assessment MDA (μmol L-1) (pre vs post): 0.88±0.01vs 0.77±0.01, p<0.001 Yes -12.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (MDA) 2 months
    Total antioxidant capacity (mmol L-1) (pre vs post): 0.40±0.08vs 0.49±0.11, p<0.001 22.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (total antioxidant capacity)
    IL-6 (ng L-1) (pre vs post): 3.00±1.48 vs 2.09±1.25, p<0.0001 -30.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (IL-6)
    Homeopathy (n=2)
    Cavalcanti et al. (2003) [16] Uremic pruritus Homeopathic verum medicationd administered Placebo medication administered Validated scale Pruritus score (pre vs 15 vs 30 vs 45 vs 60 days): 65±25 vs 46±29, p=0.002 vs 41±30, p=0.002 vs 42±29, p=0.002 vs 38±33, p=0.004 Yes -29.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pruritus score, pre vs 15 days), -36.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pruritus score, pre vs 30 days), -35.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pruritus score, pre vs 45 days), -41.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pruritus score, pre vs 60 days) 60 days
    Silveira et al. (2019) [64] Renal function Brazilian green propolis pills BID x 3 months Placebo pills BID x 3 months Immunoturbidimetry, ELISA Proteinuria (mg/24 h) (T vs C, baseline vs 12 months): 695 (95{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} CI, 483 to 999) vs. 1403 (95{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} CI, 1031 to 1909); p=0.004 Yes -27.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (proteinuria) 12 months

    Tools used for outcomes assessments of symptoms during interventions are as follows: the most frequently utilized tools were the abbreviated version of the World Health Organization Quality of Life-100 Questionnaire (n=2) and visual analog scale (n=2).

    Risk of bias within studies: Out of all included studies, 14 (42.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) studies were assessed to be of “low” risk of bias, nine (27.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) and 10 (30.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) studies were scored as “some concerns” and “high” risk of bias, respectively.

    Results of Individual Studies

    Traditional Chinese medicine: The most commonly utilized interventions in the studies were herbal treatments (n=14, 70{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [17, 37-43, 45-49, 51, 52] followed by acupuncture (n=6, 30{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [3,7,36,38,44,50]. For acupuncture treatment, five studies used conventional acupuncture [3,7,36,38,50] while one study used infrared stimulation of acupoints [44]. The common acupoints administered during conventional acupuncture treatment were Li11 (n=3, 60{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), ST36 (n=2, 20{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), and Li4 (n=2, 20{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}). The frequency of acupuncture ranged from once a week to once a day, whereas the duration of studies lasted between six weeks to six months. Uremic pruritus (n=3, 60{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) was the most commonly studied indication, with reductions in pruritus score observed between 54.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} and 60.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} [7,36,38]. Infrared stimulation was used on RN6, RN4, and RN3 thrice a week for three months [44]. The indication studied was quality of life (QoL). According to QoL scores that were evaluated using the EQ-5D questionnaire, utility increased by 15.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}.

    Herbal treatments include six single-herb (n=6, 42.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [39-42,48,49,51] and eight multi-herbs formula granules (n=8, 57.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [17,37,41,43,45-47,52]. Common single-herb treatments used are Huangkui (n=2, 33.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) and TWHF (n=2, 33.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}). The frequency of treatment was once to three times a day, for two to 12 months. Proteinuria was the most studied indication (n=4, 66.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), where the various treatments reduced proteinuria between 27.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} and 61.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} [39,42,48,51]. Common herbs used in the multi-herb formula granules studies included Huang Qi (n=6, 75{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), Danggui (n=4, 50{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), Salvia miltiorrhiza (n=3, 37.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), and Poria (n=3, 37.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}). The most commonly studied indication was improvement in renal function (n=5, 62.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [17,41,43,47,52]. Serum creatinine decreased (2.76-12.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) and eGFR increased (7.07-15.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) across the various treatments.

    Ayurveda: The included studies evaluated both plant-based (n=3, 50{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [53,54,56] and animal-based (n=3, 50{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) treatments [55,57,58]. The most common treatment studied was plant-based silymarin tablets (n=2, 33.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) while that for clinical indication was improvement in renal function (n=4, 66.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [53-56]. The eGFR increased between 16.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} and 86.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} across the various treatments [53-56].

    Naturopathy: Keto amino acids were the most studied naturopathic treatment (n=2, 40{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}). Common indications studied included anemia and glucose control, where hemoglobin and fasting blood glucose levels in subjects improved by 19.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} and 20.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, respectively [60,61]. The use of watercress and garlic extract was also studied for inflammation, where the total oxidant status and IL-6 levels were shown to improve by 38.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} and 68.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, respectively.

    Homeopathy: Homeopathic verum was studied for relief of uremic pruritus with improvement in pruritus score between 29.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} and 41.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} [16]. For Brazilian green propolis pills, it was studied for proteinuria where a 27.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} reduction in proteinuria was noted [64].

    Safety Profile of AMS Interventions

    The adverse events reported by all included studies are shown in Table 3. Adverse events reported were of grade 1 (n=13, 39.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), grade 2 (n=8, 24.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), and grade 3 (n=6, 18.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) severity. There were no life-threatening consequences or death related to adverse effects (grades 4 and 5) reported.

    Study (year) N (T) Treatment Reported adverse effects based on Common Terminology Criteria for Adverse Effects (CTCAE) v5.0a,b,c Onset of adverse effects (if available) Management and outcomes of patients
    Grade 1 ({fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) Grade 2 ({fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) Grade 3 ({fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c})
    Traditional Chinese medicine (n=19)
    Chenet al. (2013) [37] 95 9.6 g of Shenqi particle TID x 48 weeks NI Interstitial pneumonia (n=1, 1.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) Lung infection (n=5, 5.26{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); liver injury (n=3, 3.15{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NI NI
    Geet al. (2013) [39] 34 40 mg Tripterygium Wilfordii Hook F TID x 3 months Vomiting (n=13, 38.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) Hyperkalaemia (n=8, 23.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); Leukopenia (n=1, 2.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); Photosensitive dermatitis (n=3, 8.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NA NI Patient with decreased white blood cell withdrawn from the study
    Liet al. (2020) [42] 735 Huangkui capsule TID x 12 months NA NA Upper respiratory tract infections (n=21, 2.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NI NI
    Zhanget al. (2014) [51] T1:133 T2:136 T1: Huangkui capsule TID x 6 months T2: Huangkui capsule TID and Losartan potassium tablet QD x 6 months  Elevated cholesterol (T1: n=5, 3.76{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}; T2: n=4, 2.94{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) Upper respiratory tract infections (T1: n=4, 3.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}; T2: n=4, 2.94{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) Liver injury (T1: n=3, 2.26{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NI NI
    Xionget al. (2020) [48] 62 60 mg Tripterygium Wilfordii Hook F and 160 mg valsartan QD x 24 weeks Itchy skin (n=4, 6.45{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); nausea (n=3.22{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); rash (n=1, 1.61{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NA Liver dysfunction (n=12, 19.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); leukopenia (n=1, 1.61{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NI NI
    Liet al. (2015) [41] 122 8 g Tangshen Formula granules and angiotensin receptor blockers BID x 24 weeks NA Anaemia (n=2) Acute myocardial infarction (n=5) NI NI
    Maet al. (2013) [43] 25 150 mL zishentongluo solution BID x 3 months NA NA NA NA NA
    Wanget al. (2012) [17] T1:192 T2:191 T1: TCM granules BID x 24 weeks T2: TCM granules BID and 10 mg benazepril QD x 24 weeks Dry cough (T2: n=2, 1.04{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); Gastrointestinal symptoms (T1: n=7, 3.64{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}; T2: n=3, 1.57{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) Anaemia (T1: n=7, 3.64{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}; T2: n=6, 3.14{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) Liver injury (T1: n=2, 1.04{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}; T2: n=5, 2.61{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); hyperkalaemia (T1 n=7, 3.64{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}; T2 n=18, 9.42{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NI NI
    Yuet al. (2017) [50] 28 Acupuncture at Li4, ST36 and K13 acupoint QD x 3 months Mild pain, bleeding and bruising in some patients  NA NA NI Symptoms resolved spontaneously without any treatment
    Zhaoet al. (2020) [52] 171 Herbal granules TID x 6 months Mild abnormal liver function test (n=5, 2.92{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); Mild discomfort (n=2, 1.17{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NA   NI NI
    Xianget al. (2016) [47] 51 QDDHGb tablets BID x 12 weeks Insomnia (n=1, 1.96{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NA NA NI NI
    Xuet al. (2016) [49] 91 500 mg GS-Rb1 (ginseng extract) QD x 6 months  NA NA NA NI NI
    Che-yiet al. (2005) [36] 20 Acupuncture at Quchi (L11) acupoint TIW x 1 month Elbow soreness (n=2; 10.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NA NA NI Symptoms resolved spontaneously after 1 day.
    Gaoet al. (2002) [38] 34 Acupuncture at Quchi (L11) and Zusanli (ST 36) acupoint BIW x 1 month NA NA NA NA NA
    Nahidiet al. (2018) [7] 15 Acupuncture at various acupoints TIW x 6 weeks NA NA NA NA NA
    Onoet al. (2015) [3] 23 Acupuncture QIW x 2 months NA NA NA NA NA
    Suet al. (2009) [44] 31 Infrared stimulation of Qihai (RN6), Kuamyuan (RN4) and Chungchi (RN3) TIW x 3 months NA NA NA NA NA
    Wanget al. (2019) [45] 41 Qingshen granules TID x 3 months NA NA NA NA NA
    Wanget al. (2020) [46] 136 Qingshen granules TID x 3 months NA NA NA NA NA
    Liet al. (2009) [40] 32 Tianbaoning tablets (gingko extract) TID x 8 weeks NA NA NA NA NA
    Ayurveda (n=6)
    Alamet al. (2020) [53] 70 Sativa oil QD and alpha-keto amino acid tablets TID x 3 months NA NA NA NA NA
    Fallahzadehet al. (2012) [54] 30 140 mg silymarin tablet QD x 3 months Nausea and vomiting (n=3, 10{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); headache (n=2,6.67{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NA NA NI NI
    Hoseiniet al. (2019) [55] 22 Camel milk BID x 3 months NA Abdominal pain (n=1, 4.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NA NI NI
    Khajehdehiet al. (2011) [56] 28 140 mg silymarin TID x 3 months NA NA NA NA NA
    Makhlough et al. (2010) [57] 17 0.03{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} capsaicin ointment QID x 4 weeks NA Severe skin burning (n=1, 2.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NA NI NI
    Pingaliet al. (2020) [58] 18 1000 mg of beleric capsule taken QD Mild gastrointestinal intolerance (n=2, 11.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NA NA NA NA
    Naturopathy (n=5)
    Khanet al. (2014) [60] 80 Alpha-keto amino acid tablets TID x 3 months Nausea (n=5, 6.25{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); diarrhoea (n=5, 6.25{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NA NA NA NA
    Prakashet al. (2004) [61] 21 Keto amino acid tablets QD x 9 months NA NA NA NI NI
    Sedaghattalabet al. (2021) [62] 22 Watercress extract QD x 1 month NA NA NA NA NA
    Zareet al. (2019) [63] 19 Garlic extract tablets TIW x 2 months NA NA NA NI NI
    Boldajiet al. (2019) [59] 22 Pomegranate juice TIW x 2 months Stomach discomfort (n=1, 4.54{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NA NA NI NI
    Homeopathy (n=2)
    Cavalcantiet al. (2003) [16] 11 Homeopathic verum medicationc administered NA NA NA NA NA
    Silveiraet al. (2019) [64] 18 Brazilian green propolis pills BID x 3 months NA NA NA NA NA

    Adverse effects associated with traditional Chinese medicine: the use of acupuncture is associated with mild pain, bleeding, bruising, and elbow soreness (grade 1) [36,40]. These symptoms resolved spontaneously without additional treatment. For single-herb treatments, TWHF treatment was associated with vomiting (38.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, grade 1), itchy skin (6.45{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, grade 1), nausea (3.22{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, grade 1), and rash (1.61{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, grade 1) [39,48]. Grade 2 adverse events associated with its use included hyperkalemia (23.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), leukopenia (2.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), and photosensitive dermatitis (8.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), while grade 3 adverse effects included liver dysfunction (19.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) and severe leukopenia (1.61{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}). Subjects who developed leukopenia were withdrawn from the study.

    For Huangkui treatment, adverse effects observed included elevated cholesterol (2.94-3.76{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) (grade 1), upper respiratory tract infection (2.94-3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) (grade 2 and grade 3), and liver injury (2.26{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) (grade 3) [42,51]. The use of Shenqi particles was associated with interstitial pneumonia (1.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, grade 2), lung infection (5.26{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, grade 3), and liver injury (3.15{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, grade 3) [37]. Anemia (grade 2) and acute myocardial infarction (grade 3) were observed for subjects using Tangshen formula granules [41]. The use of QDDHG tablets was associated with insomnia (1.96{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, grade 1) [47].

    Adverse effects associated with ayurveda: Silymarin treatment was associated with nausea and vomiting (10{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), as well as headache (6.67{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [54,56]. Beleric capsule treatment was associated with mild gastrointestinal intolerance (11.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [58]. Adverse effects from both studies were of grade 1 severity. Abdominal pain (4.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, grade 2) was observed with the treatment of camel milk [55].

    Adverse effects associated with naturopathy: All adverse effects reported for naturopathy treatments are of grade 1 severity (Table 3). They include nausea (6.25{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) and diarrhea (6.25{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) with the use of alpha-keto amino acid [60], as well as stomach discomfort (4.54{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) with the use of pomegranate juice [59].

    Adverse effects associated with homeopathy: No adverse effects were reported with the use of homeopathy (Table 3).

    Summary of Efficacy and Safety Profile of AMS Interventions

    Table 4 shows a summary related to the efficacy and safety profiles of AMS interventions.

    Type of AMS Common doses and treatment regimens and duration of therapy Indications Percentage reduction in CKD symptoms (if available) Adverse effects reported ({fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c})
    TCM (n=20) [3,7,17,36-52] Herbal Renal function 2.76{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to 51.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} Elbow soreness (10{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); liver injury and dysfunction (1.04-19.40{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); dry cough, pneumonia, and upper respiratory infections (1.04-5.26{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); hyperkalemia (3.64-23.50{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); vomiting (38.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); leukopenia and anemia (1.61-2.90{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); photosensitive dermatitis, itchy skin, and rash (1.65-8.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); gastrointestinal symptoms, nausea, and vomiting (1.57-38.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); insomnia (1.96{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c})
    Herbal granules TID x 6 months; QDDHG tabletsa BID x 12 weeks; 500 mg GS-Rb1 QD x 6 months; 8 g TSF granules and ARB BID x 24 weeks; 150 mL ZSTL solution BID x 3 months; TCM granules BID x 24 weeks
    Acupuncture
    Acupuncture at Li4, ST36 and K13 acupoint QD x 3 months
    Herbal Proteinuria -61.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to -18.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    9.6 g of Shenqi particle TID x 48 weeks; 40 mg TWHF TID x 3 months followed by 20 mg TWHF TID x 3 months; Huangkui capsule TID x 12 months; 60 mg TWHF and 160 mg valsartan QD x 24 weeks
    Acupuncture Uremic pruritus -60.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to -54.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Acupuncture at Quchi (L11) acupoint TIW x 1 month; acupuncture at Quchi (L11) and Zusanli (ST 36) acupoint BIW x 1 month; acupuncture at various acupoints TIW x 6 weeks
    Acupuncture QIW x 2 months Fatigue, insomnia, itchiness, and pain -89.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to 15.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Infrared stimulation of Qihai (RN6), Kuamyuan (RN4) and Chungchi (RN3) TIW x 3 months QoL -9.10{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to 163{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Qingshen granules TID x 3 months Wnt/β-catenin signaling pathway -61.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to 17.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Qingshen granules TID x 3 months Immune function 42.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to -20.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    TBN tablets (gingko extract) TI x 8 weeks Vascular endothelial function 44.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to 40.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Ayurveda (n=6) [53-58] Plant-based Renal function -56.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to 86.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} Nausea, vomiting, and headache (6.67-10{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); abdominal pain (4.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) severe skin burning (2.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c})
    Sativa oil QD and alpha-keto amino acid tablets TID; 140 mg silymarin TID x 3 months; 140 mg silymarin tablet QD x 3 months
    Animal-based
    Camel milk BID x 3 months
    0.03{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} capsaicin ointment QID x 4 weeks Uremic pruritus -84.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    1000/500 mg of beleric capsule taken QD Hyperuricemia -24.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to 40.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Naturopathy (n=5) [59-63] Alpha-keto amino acid tablets TID x 3 months; Keto amino acid tablets QD x 9 months Malnutrition 39.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to 49.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} Nausea (6.25{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); diarrhea (6.25{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); stomach discomfort (4.45{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c})
    Watercress extract QD x 1 month; garlic extract tablets TIW x 2 months Inflammation -73.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to 26.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Pomegranate juice TIW x 2 months Hypertension, stress, and inflammation -30.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to 22.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Homeopathy (n=2) [16,64] Homeopathic verum medicationb administered x 60 days; Brazilian green propolis pills BD x 3 months Uremic pruritus -41.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to -29.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Renal function -27.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}

    Discussion

    To the best of our knowledge, this is the first review that has summarized findings related to the therapeutic uses of AMS for CKD patients in RCTs. Among the four classes of AMS, TCM was the most studied class which has demonstrated efficacy in improving CKD-related symptoms and outcomes [3,7,36-52]. Among the TCM interventions evaluated, Huangkui, TWHF, and acupuncture have shown efficacy in reducing proteinuria and relieving uremic pruritus symptoms. The therapeutic basis of TCM for CKD is rooted in the restoration of vital energy and nourishment of blood, dispelling of heat and reduction of dampness, and regulation of Yin and Yang in the body [65]. In Western medicine, this is seen in a reduction in inflammation and oxidative stress, as well as boosting micro-circulation and enhancement of metabolism [52]. For example, Huangkui, also known as Abelmoschus manihot, reduces proteinuria by removing oxygen radicals, improving the circulation, and clearance of immune complexes as well as reducing inflammation and renal tubular epithelial injury [66]. It is also noted that triptolide, the key constituent of TWHF, suppresses the nuclear factor kappa b (NF-κB) signaling pathway and prevents the trigger of T lymphocytes and some inflammatory cytokines (TNF-α, IL-1β, IL-6, and IFN-γ), in addition to its podocyte-protective capabilities [67-70]. Notably, two of the included studies demonstrated that a combination of TCM and Western medicine, such as the intake of Huangkui capsule and losartan tablet to alleviate proteinuria, is more efficacious than taking TCM or Western medicine alone. This adds to existing evidence on potential applications of TCM alongside conventional medical therapy. Among patients on TWHF, regular checks of potassium and liver enzymes should be performed due to the risk of hyperkalemia and raised liver enzymes.

    With regards to the use of acupuncture, it results in the release of endogenous opiate-like substances that have been proposed to dull the peripheral and central perception of itching [71]. Stimulation of acupoints via far infrared (FIR) treatments has also been revealed to boost skin microcirculation, lessen emotional anxiety and promote excretion of waste products by improving the autonomic nervous system [44,72-76]. Enhanced circulation via a stronger autonomic nervous system is postulated to relieve CKD-related symptoms as the development of renal failure is attributed to poor circulation in the field of TCM [73,77]. Currently, renowned hospitals in the United States such as the Mayo Clinic and Duke University Medical Center have started providing acupuncture, along with other treatments. With growing evidence related to the efficacy and safety of TCM, there has been greater receptivity from medical doctors related to applications and use of TCM in clinical practice [78]. It is however important to note that TCM is not without any side effects. For example, the use of Huangkui should be cautioned in patients with hyperlipidemia or liver disease as its use has been associated with elevated lipid levels and liver injury. On the other hand, acupuncture appears to be relatively safe with mild side effects, such as elbow soreness. More studies related to TCM are required to further assess their long-term safety profile, and they should be prescribed with careful consideration of each patient’s health condition.

    For Ayurveda, silymarin was one of the most studied interventions which demonstrated efficacy in improving renal function. Ayurvedic therapies are derived predominantly from plants, animals, minerals, exercise, and lifestyle changes. They are believed to rejuvenate and remove toxins from one’s body. In conventional medicine, the therapeutic effects of ayurveda for CKD are ascribed to their anti-inflammatory and anti-oxidant properties. For instance, silymarin has shown efficacy in in vitro studies in attenuating inflammatory stress in renal tissue by suppressing the NF-κB signaling pathway and hence TNF production [79-85]. Other Ayurvedic treatments, such as the application of capsaicin ointment, were also found to alleviate uremic pruritus. Topical capsaicin, a natural alkaloid derived from red chili pepper, has been discovered to relieve uremic pruritus by binding specifically to type C sensory neurons and resulting in the release of substance P, as well as suppressing its synthesis, transport, and storage thereafter [57]. Relatively few side effects were observed for the Ayurvedic therapies discussed above. Despite the promising benefits associated with Ayurvedic treatments, it is currently less globally recognized as compared to TCM [86]. Further research is necessary to evaluate their efficacy and safety profile to improve their acceptance in clinical practice as adjunctive treatments, in particular for CKD patients.

    For naturopathy, its unique attribute lies in the reprioritization of the order of therapeutics, with increased emphasis on non-invasive treatments, such as lifestyle modifications and nutrition, over medical or surgical interventions. In this review, one of the more studied interventions is the use of ketoanalogues of essential amino acids (KAs). The addition of KAs to a low-protein diet has been shown to improve renal function and uremia. Notably, while lowering protein intake may improve renal function in CKD patients by altering immunologic events and reducing hypertrophy and hyperfiltration in the remaining nephrons, it may result in malnutrition [87-89]. However, the supplementation of KAs not only averts malnutrition by ensuring adequate consumption of amino acids but also alleviates uremia [61]. The absence of amino nitrogen in KAs allows them to become transaminated by taking nitrogen from non-essential amino acids and hence, reducing the production of urea via re-using the amino group [90,91]. Relatively few and mild adverse effects were observed for the included naturopathic therapies, rendering them attractive treatment options. Additionally, as naturopathic treatments are usually non-invasive, they can be easily combined with conventional medications. Of note, 28 health systems, hospitals, and cancer treatment centers in the United States currently have at least one licensed naturopathic physician at their premises [92]. With increasing research evaluating the efficacy and safety profile of naturopathic treatments, its role as potential adjunctive treatment for CKD patients is also likely to expand in the future.

    Lastly, homeopathy has also shown efficacy in improving CKD-related symptoms and outcomes. Homeopathy entails the therapeutic administration of substances derived from plants, minerals, or animals which produce effects that correspond to the clinical manifestation of diseases. In this review, the use of Brazilian green propolis pills and homeopathic verum medication were found to improve renal function and alleviate uremic pruritus, respectively. Brazilian green propolis was reported to improve renal function via a few mechanisms. Firstly, it decreases proteinuria via its ability to reduce urinary oxidative stress and macrophage infiltration into the kidneys [93]. Secondly, chrysin, a flavonoid in propolis has been shown to decrease podocyte apoptosis in patients with diabetic nephropathy and lessen glomerular injury [94]. Lastly, propolis has also been shown to decrease blood pressure via acetylcholine-induced vasodilation and from its antioxidant properties [93,95-97]. With regard to the safety of homeopathic treatment, no adverse effects were reported across included studies. However, the practice of homeopathy is relatively restricted, with 36{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of states in the United States requiring homeopathic practitioners to either be licensed Western medicine or Naturopathic practitioners [32]. Consequently, more research is necessitated to validate the efficacy and safety of homeopathic treatment as adjunctive therapy for CKD patients.

    Limitations

    The following limitations should be considered in conjunction with this review. Firstly, due to the clinical and methodological heterogeneity of the studies, meta-analyses were not performed. As the pool of evidence for AMS trials for CKD patients grows, subsequent reviews should consider conducting meta-analyses for the efficacy of AMS treatments for CKD patients. In addition, there could have been exclusion of potentially applicable studies even though an extensive search strategy was used. To prevent this, the references of included studies were also hand-searched as part of our search strategy. Another limitation of the study relates to the inclusion of only articles in English language. Researchers should consider the inclusion of studies in other languages such as Chinese and Tamil in future reviews. Finally, although results of the included studies were reported normalized Z scores, care should be taken when interpreting these values and comparing the efficacy of various AMS classes. This is due to considerable diversity in types of outcomes evaluated and comparator arms and tools adopted for evaluation of outcomes. Overall, it is hoped that with greater standardization of study outcomes for AMS therapies in future studies, these normalized Z scores can enable more purposeful comparisons of the efficacy of the different AMS classes.

  • [SCAM] Tiger Woods CBD Gummies Review – Joel Osteen CBD Gummies Scam Or Fake Exposed Taylor Swift cbd gummies?

    [SCAM] Tiger Woods CBD Gummies Review – Joel Osteen CBD Gummies Scam Or Fake Exposed Taylor Swift cbd gummies?

    Tiger Woods CBD Gummies  Stress and anxiety have been a consistent part of modern human being’s life, and it could be due to differences in relationships, unhealthy lifestyles, erratic food habits, and professional stress to perform well and climb the ladder in the organization while being recognized and achieving accolades along the way. Nutritional supplements, especially Tiger Woods CBD Gummies, can help him by improving his physical and mental health.

    Tiger Woodss has come up with a uniquely effective as well as an efficient product called Tiger Woods CBD Gummies that can tackle human physical and mental imbalances due to hormonal imbalances, which in turn are due to stress and anxiety.

    (ACT NOW & SAVE) Click Here to Buy CBD Gummies From The Official Website

    What are CBD gummies?

    CBD Gummies are tasty candies that can help in weight loss, enhance healthy brain cells and improve memory. They can also positively affect detoxification and hormone release.

    How are Tiger Woods CBD Gummies made, and what do they contain?

    Tiger Woods CBD Gummies are extracted from non-toxic Cannabidiol (CBD) plant sources like Hemp plants due to their non-THC suitability.

    They contain the following ingredients:

    Hemp plant

    A non-intoxicating, low Tetrahydrocannabinol (THC)-containing cannabis source is used, thereby eliminating the hallucinogenic effects.

    Pectin

    It is extracted from fruit wall cells and added to get the jelly-like texture of the gummies

    Malic acid

    Used as the flavouring agent

    Organic Tapioca syrup

    It is natural and helps in supporting the chemical bond of CBD gummies.

    Citric acid

    Adds the zing to the gummies

    GarciniaiaCambogia extract

    Essence of Lavender

    Eucalyptus

    Coconut Oil

    Eatable Flavors

    CLICK HERE- ”CBD GUMMIES OFFICIAL WEBSITE”

    how do Tiger Woods CBD Gummies work?

    The Cannabidiol present in the Tiger Woods CBD Gummies acts with the CB1 and CB2 receptors, which further replenish the Endocannabinoid system (ECS); this ECS helps maintain natural balance and proper functioning of all body functions.CB1 and CB2 receptors are members of the G protein-coupled receptor family, and they possess the ability to recognize agonist and antagonist compounds and produce a myriad of effects. Ageing-related changes and other chronic diseases can cause an imbalance in the ECS system leading to chronic pain, which is alleviated by Tiger Woods CBD Gummies.

    What are the uses of Tiger Woods CBD Gummies?

    They are useful in maintaining a homogenous balance in the body’s physical and mental status.

    The Cannabidiol present in these gummies reduces anxiety and stress

    Helps address neurodegenerative disorders arising due to ageing

    They act on CB1 receptors and alleviate body pain

    Their interaction with the ECS system by CB1 and CB2 receptors helps in maintaining homeostasis.

    They increase mental stability by reducing anger and rage

    Improve blood circulation

    They help to regenerate nerves

    They increase immunity

    Overall physical strength is improved

    They act as antioxidants

    They have anti-inflammatory action

    Help in weight loss

    Aid in keeping the mind calm and relaxed

    They raise the energy levels of the body

    It increases Metabolism

    Decreases chronic pain

    Improves sleep

    Help in coping with fight or flight situations

    are there any side effects?

    Since a non-THC-based Cannabidiol is used, the mind-altering effects are kept at bay, and they are safe without any known side effects. When used in excessive doses, it can cause dry mouth and gut discomfort.

    in what forms are the Tiger Woodss cbd products available?

    They are available in various forms, like

    Edibles

    Soft gels

    Balms

    Liquids

    Roll-ons

    Syrup – immunity

    Pet CBD oil is available too

    unique features of Tiger Woodss cbd products

    Our products are unique in their ways as we take care in each aspect of their production to deliver a product of the utmost quality.

    Nutrient-rich product

    Our hemp extracts are full spectrum and contain more than 500 bio-active ingredients like vitamin e and fatty acids.

    Non-Psycho-toxic

    Our products contain THC well within the prescribed limits and are free from hallucinogenic effects.

    Eco-friendly

    We grow our agricultural hemp in nature, thereby aiding in replenishing the soil, as this process sequesters the Co2 and requires less moisture.

    [HUGE SAVING] CHECK PRICE FOR CBD GUMMIES APPLIED DISCOUNT CODE

    what is the entourage effect?

    It is a process by which various inactive components of Cannabis work with active ingredients to make them efficacious.

    CBD interacts with the cannabinoid receptors and increases anandamide and various brain neurotransmitters such as dopamine, GABA, serotonin, and glutamate. It also interacts with mitochondria and cell membranes and helps in genetic transcription.

    We at CVS Sciences use this Entourage effect to the maximum benefit of our customers through our manufacturing process, where we preserve the terpenes by extracting the Co2 gently, save cannabinoids, and retain fatty acids, alkaloids, and flavonoids.

    why is the endocannabinoid system important?

    The Endocannabinoid system is very important since it virtually affects the entire human body and provides an overall positive effect by reducing stress, increasing sleep, and impacting our mood positively.

    It mediates systemic health by affecting the Immune, digestive and nervous systems also affect the brain, liver, spleen, endocrine glands, heart, lung, bone, muscles, skin, blood vessels, fatty tissue, blood cells, and lymph cells.

    It regulatesMetabolism, pain, inflammation, stress response, muscle control, mood, and sensation.

    common faqs related to CBD

    Will CBD get me high?

    No, it doesn’t get you high, as the percentage of TCH is almost zero

    What is its origin?

    It is extracted delicately by organic farming from agricultural hemp, by a chemical-free Co2 extraction method

    Why is it useful?

    It creates a positive impact on almost the entire physiological system

    Is it legally allowed?

    Yes, by the United States Farm Bill of 2018, where hemp containing less than 0.3 TCH can be sold.

    Fears about Drug testing

    We advise you not to consume our products if you fear the results of a drug test as our products are not completely TCH-free.

    Are they safe?

    Our products are prepared with due care, from the seed to the shelf, the entire process is carefully monitored, and various third-party quality checks are undertaken. As we believe in complete transparency, the results of all such tests are available for your discretion.

    Tiger Woodss Products Range:

    Various products available online are:

    Immunity

    CV Acute Intensive Immune Support; $34.99

    EDIBLE

    CBD Calm Gummies; $34.99

    CBD Gummies 10mg; $32.99

    6-pack Happy Lane Chews (0.00{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} THC); $95.94

    CBD Sleep Gummies; $34.99{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}

    SOFTGELS

    CBD Softgel Capsules 15mg; $44.99

    CBD Softgel Capsules 10mg; $48.99

    CBD Softgel Capsules 50mg; $84.99

    BALMS

    CBD Pain Relief Sports Recovery Stick 1OZ; $34.99 onwards

    CBD Balm 100mg 1.3OZ; $34.99 onwards

    CBD Travel Size Balm 45MG 0.42OZ; $14.99 onwards

    LIQUIDS

    CBD Oil 100mg Unsweetened; $54.99

    CBD Oil Extra Strength; $34.99

    CBD Oil 1500mg; $119.99

    CBD Spray; $19.99

    ROLL-ONS

    6 Pack –Happy Lane CBD Roll-On (0.00{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} THC); $119.94

    CBD Roll-On; $27.99

    PET CBD OIL (Pet Formula)- 5mg CBD per serving

    PET CBD OIL 500mg Beef; $44.99 onwards

    PET CBD OIL 500mg Peanut Butter; $44.99 onwards

    PET CBD OIL 500mg Chicken; $44.99 onwards

    TIGER WOODSS CBD PRODUCTS COME IN THREE PRODUCT LINE RANGES

    PLUS CBD

    CBD Calm Gummies; $34.99

    CBD Gummies 10mg; $32.99

    CBD Oil 1500mg; $119.99

    CBD Balm Hemp Stick; $22.99

    CBD Spray; $19.99

    CBD Sleep Gummies; $34.99

    CBD Softgel Capsules 15mg; $44.99

    CBD Travel Size Balm; $14.99

    CBD Softgel Capsules 50mg; $84.99

    CBD Roll-On; $27.99

    CBD Softgel Capsules 10mg; $48.99

    CBD Oil Extra Strength; $34.99

    CBD Oil 500mg Unsweetened; $54.99

    CBD Balm; $34.99

    Pet CBD Oil; $24.99

    HAPPY LANE

    6 Pack- Happy Lane CBD Roll-On (0.00{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} THC); $119.94

    6 Pack- Happy Lane Chews (0.00{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} THC); $95.94

    IMMUNITY

    CV Acute Intensive Immune Support; $34.99

    These products have been clinically shown to drastically improve the immune response

    They are divided into two categories

    CV DEFENSE

    Daily Immune Support

    Created to boost daily immune response

    The ingredients include PEA, Vitamin A & D, Selenium, Zinc, and reishi mushroom extract

    CV ACUTE

    Designed to tackle extraordinary challenges to the immune system

    Based on Traditional Chinese Medicine (TCM)

    PLUS CBD of TIGER WOODSS has recently introduced a novel line of products called the RESERVE collection

    Higher standard distillation and blending techniques are used to derive the most authentic hemp-derived THC.

    These products maintain the ratio of CBD to THC in the range of 10:1 to 20:1, or 0.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} and each Reserve product has around 2.5gm THC per serving, well under the range prescribed in the guidelines of the US Farm Bill and most European Standards.

    most frequently asked questions regarding cbd (in detail):

    What does CBD stand for?

    CBD is the abbreviation for Cannabidiol. It belongs to represent any ofthe cannabinoids, which represent a spectrum of chemical compounds usually found in hemp and marijuana plants.

    113 varieties of cannabinoids have been identified and CBD is just one of them.

    Is it safe to use CBD oil?

    Yes, using CBD oil is safe as our products are manufactured using high-standard procedures that go through several Quality checks

    Caution should be taken when using it for the first time, you are advised to use small amounts initially and then increase the dose if you don’t encounter any issues, however, if you are concurrently using a medication, take an expert opinion.

    CanCannabidiolbe purchased through prescription?

    A prescription is generally not needed to buy CBD, it is sold as an over-the-counter food supplement.

    Does CBD show up in Drug, Follicle, and Blood tests?

    CBD generally doesn’t show up in drug tests but some CBD oils contain THC which can give an adverse result.

    CBD doesn’t show up in hair follicle test

    CBD can be shown in the blood test

    Does CBD get you high?

    No, it doesn’t as it most often contains no THC

    Is it legal to buy CBD in the US

    As long as the THC content remains less than 0.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} it is legal in the United States.

    Can you get addicted to CBD?

    No, Since CBD doesn’t contain THC, which is responsible for the psychotic effects, you can’t get addicted.

    What are the side effects of CBD?

    Usually, there are no side effects, however, if taken in large doses or too frequently, they can cause mild gastric upset.

    In such situations discontinue use for some time.

    How does CBD make you feel?

    It gives a feeling of well-being and provides a positive outlook.

    Does CBD make you sleepy?

    CBD causes you to relax and doesn’t cause sleep or drowsiness.

    How long does it take to act and how long does it last?

    The effects vary from person to person

    Usually, one dose is sufficient per day but a CBD patch can last up to 2-3 days and a 10 ml CBD bottle can last from 3-5 weeks. Its effects can last from 2-6 hours.

    How long does it stay in the system?

    It can stay in the body for any time between 2-5 days.

    How can CBD products be used?

    These products have accompanying instructions

    CBD oil drops, a few minutes before swallowing few drops are to be held on the underside of the tongue.

    Topical CBD creams and CBD patches are applied on the skin

    Gummies are for chewing

    What medicine should be avoided with CBD?

    Due to the possibility of drug interactions, the following shouldn’t be taken with CBD, and medical opinion should be taken.

    Steroids

    Antihistamines

    Antibiotics

    Anesthetics

    Antipsychotics

    Antidepressants

    Anti-epileptics

    Does CBD cause anxiety and Headaches?

    No, it heals the patient suffering from anxiety and headache

    Can CBD cause hallucinations?

    No, it can’t cause hallucinations as it doesn’t contain THC

    Can CBD cause psychosis?

    No, it doesn’t cause psychosis

    Can CBD help with depression?

    Yes, it can help with depression and give you a happy and positive feeling

    Can CBD make you hungry?

    No, it can’t make you hungry as it doesn’t contain THC

    Is CBD safe for children?

    No, it should not be given to minors

    Is CBD safe during pregnancy and lactation?

    No, it is not advised to use CBD during pregnancy and lactation.

    Benefits of Tiger Woods CBD Gummies.

    It helps to revitalize wellness from clinical stress, depression, and anxiety.

    It removes body discomfort and alleviates joint pain by acting through the endocannabinoid system.

    It is 100{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} natural, hence does not create any side effects.

    It boosts gut health and wellness

    It boosts the metabolic process.

    It decreases inflammation and helps in reducing pain in arthritis patients.

    It can kill some selections of cancer cells

    It improves cognitive power and boosts brain activity.

    VISITING OFFICIAL WEBSITE BY TAPPING HERE “GET YOUR ORDER NOW”

    Testimonials

    Erick:” I was having difficulty concentrating, and my brain used to seem foggy and hazy; after searching online, I came across a miracle product called Tiger Woods CBD Gummies; after taking one dose daily for about two months, my situation improved drastically.”

    Clara: “I was going through a phase of depression and had negative thoughts frequently; a friend suggested Tiger Woods CBD Gummies, I was hesitant, but the results proved me wrong. Now I stay positive and happy most of the time, thanks to Tiger Woods CBD Gummies.”

    Stephen: “Insomnia was something I thought I couldn’t ever get rid of, but amazingly it was cured in 4-6 weeks due to Tiger Woods CBD Gummies; I never thought it could be possible; the best part is that not only the quantity but also the quality of sleep has been improved tremendously.”

    George R: “I had severe pain in my knee ad fingers due to arthritis; my friend suggested I take Tiger Woods CBD Gummies; I thought he might be crazy, frankly speaking, I can’t thank him enough now that I feel more comfortable because my pain has almost vanished.”

    CLICK HERE- ”CBD GUMMIES OFFICIAL WEBSITE”

    Conclusion:

    CBD along with many natural ingredients, when used in a sensible proportion and under strict quality control, can be turned into a miracle supplement. These supplements can have various uses ranging from reducing pain and headache to improving mental health and sleep. Many studies have been undertaken to know the beneficial effects of these supplements, and many are ongoing; most of these have shown positive and beneficial effects on humans. As time passes by, ever more discoveries are revealing more and more miraculous effects of them

    Though they can be safely used in many females, caution must be exercised in using them and ng them, and they should be avoided during pregnancy and lactation. They should not be used with minors. Various drugs may interact with these supplements and can cause unwanted adverse effects drug interactions; hence caution should be exercised, and expert medical opinion has to be taken before using congruent with other medication.

    If used judiciously, following the instructions given by the manufacturer, the Tiger Woods CBD Gummies, supplements can be an elixir to many patients, young and old alike, in treating chronic pain, headaches, insomnia, weight gain, and neuromuscular and musculoskeletal disorders-related issues.Tiger Woodss has probably the largest range in this category, from gummies to oils, to patches to capsules, syrups, etc.

    Since US Farm Bill and many European Governmental regulations suggest keeping the THC content less than 0.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, most of these products are non-addictive and free from psychotic effects, hence can be safely used in young adults without the fear of them getting addicted and spoiling their health and future.

    The Reserve product range in the basket of Tiger Woodss CBD products is one to look out

    What are you waiting for?

    Click Here to Purchase Tiger Woods CBD Gummies at Special Price Today!

     

  • FDA Officials Say Hemp And CBD Regulatory Plan Is Months Away As It Carries Out Marijuana Scheduling Review

    FDA Officials Say Hemp And CBD Regulatory Plan Is Months Away As It Carries Out Marijuana Scheduling Review

    As the Food and Drug Administration (Fda) carries out a scientific overview into marijuana that will advise its federal scheduling position, leading officers at the company say they are months absent from releasing a regulatory evaluation for hemp-dependent solutions like CBD.

    Fda has confronted major criticism in the latest many years over the deficiency of policies allowing for for the promoting of cannabis in the foods source or as dietary dietary supplements. Hemp and its derivatives were legalized beneath the 2018 Farm Bill, but the agency has lengthy maintained that far more research must be done, or Congress really should move in all over again, right before laws for consumable cannabinoid products and solutions are finalized.

    In interviews with the Wall Street Journal that was printed on Tuesday, Food and drug administration Principal Deputy Commissioner Janet Woodcock and two other officials steering the agency’s hashish coverage, Patrick Cournoyer and Norman Birenbaum, reviewed future techniques.

    “Given what we know about the basic safety of CBD so much, it raises considerations for Fda about whether these existing regulatory pathways for food and dietary dietary supplements are correct for this substance,” Woodcock stated.

    It is doable that Fda may perhaps finally punt to Congress, as officials have formerly mentioned could be needed in buy to forge a regulatory pathway for the plant.

    Meanwhile, the market for hemp, CBD and additional novel intoxicating cannabinoids like delta-8 THC is presently popular throughout the place. As these, Fda officials seem to more and more realize the urgency of rulemaking.

    “I never believe that we can have the great be the enemy of the excellent when we’re searching at these a huge current market that is so readily available and used,” Birenbaum, a former state marijuana regulator in New York and Rhode Island, told the Journal. “You’ve bought a broadly unregulated market place.”

    U.S. Hemp Roundtable said in a assertion that FDA’s responses sign that “the new year may give some promise for the lengthy-awaited regulation of hemp-derived extracts these as CBD.”

    The marketplace group explained that it would be “meeting with the Food and drug administration in early January as part of our continuing dialogue on what a regulatory scheme need to entail” and that it would also go on its advocacy on Capitol Hill in scenario the agency does need to have new legislative authority from Congress in purchase to established cannabinoid restrictions.

    The Food and drug administration officials said that a couple of details they are assessing concern no matter if CBD can be applied safely and securely in the long-time period, and what impacts intake might have in the course of being pregnant. The increase in recognition of delta-8 THC goods, which the Drug Enforcement Administration (DEA) claims are not controlled substances, has more sophisticated rulemaking.

    Birenbaum stated officials have “growing and a lot more intensifying small-time period concerns” about the results of cannabinoid products and solutions.

    “Over the past 12 months and a fifty percent, we have witnessed a total host and cadre of intoxicating hemp derived cannabinoids occur up,” he stated. “There are incredibly, very various regulatory things to consider for products and solutions that are likely to intoxicate you.”

    Birenbaum also said that the “safety profiles all over these products are not what they are frequently accustomed to and not the similar as what they get from other solutions when they walk into a wellness store or grocery keep or even a gasoline station.”

    Fda a short while ago touted its position helping a point out company crack down on a enterprise offering delta-8 THC gummies that they stated are joined to “serious adverse situations.”

    Previous month, Food and drug administration despatched warning letters to 5 companies that market meals and beverages containing CBD.

    The agency didn’t specify why it specific those certain 5 firms out of the a lot of additional that marketplace related cannabidiol-infused consumables, but it stated that they provide merchandise “that individuals may confuse for classic foods or drinks which could result in unintended usage or overconsumption of CBD.”

    Bipartisan lawmakers have continuously pressed Fda to produce that internet marketing pathway for CBD in the foods offer and as nutritional dietary supplements.

    Reps. Morgan Griffith (R-VA) and Brett Guthrie (R-KY) despatched a letter to Fda Commissioner Robert Califf in September, demanding responses over the continued deficiency of restrictions for CBD for all those uses.

    Griffith and other bipartisan lawmakers sent a independent, linked letter to the Fda commissioner in August. They expressed frustration more than the “completely inadequate response” the agency presented in reaction to their bill contacting for hemp-derived CBD to be permitted and controlled as a foodstuff additive.

    Following the CBD Product Security and Standardization Act was filed in December 2021, the sponsors sought technological guidance from Fda to suggest on crucial provisions. But 4 months soon after they sent the inquiry, Food and drug administration returned a “one-page” response that was “simply a reformatting of a doc furnished to Congress about two decades ago,” the lawmakers reported

    At a Residence Appropriations subcommittee hearing in May, FDA’s Califf regarded that the agency had moved gradually with rulemaking for CBD in the foods supply, stating that the circumstance “looks rather substantially the similar in phrases of where we are now” as as opposed to when he initially labored on the situation in 2016.

    He said the Food and drug administration has taken actions to research the security profile of cannabinoids to notify potential guidelines, but he also punted the criticism about inaction to Congress, indicating he does not feel that “the current authorities we have on the food aspect or the drug facet necessarily give us what we want to have to get the appropriate pathways forward.”

    “We’re heading to have to appear up with one thing new,” Califf explained. “I’m incredibly fully commited to performing that.”

    Stakeholders have strongly encouraged Fda to stay up to its authority and provide guidelines and clarity for the field. But the company has largely minimal its regulatory enforcement authority to sending warning letters to particular CBD organizations and denying cannabinoid marketing purposes.

    In May possibly, for illustration, the agency simply sent warning letters to four cannabis companies for allegedly producing unsanctioned statements about the health-related advantages of CBD items they’ve promoted for animals.

    Food and drug administration also warned buyers about marijuana-infused copycat food products that resemble well-known models and the risks of accidentally ingesting THC, significantly for kids.

    The company separately issued its to start with established of warnings to businesses over the allegedly illegal sale of items containing the progressively well-liked cannabinoid delta-8 THC.

    It sent 5 warning letters to companies that are advertising and marketing products and solutions with the intoxicating compound and producing what the company claims are unsanctioned promises about their therapeutic prospective.

    In May, a leading Republican on a crucial congressional committee also referred to as on leadership to schedule a listening to to keep Food and drug administration accountable for its absence of action to established restrictions for CBD and delta-8 THC products and solutions.

    All of this arrives in the background of a big process for Fda: Conducting a scientific evaluate into marijuana, at the course of President Joe Biden, to assist in an assessment of its federal scheduling. FDA’s suggestion will not be binding, but officers say they be expecting DEA to products a scheduling suggestion that’s dependable with their findings about its pitfalls and added benefits.

    Scientists Published A Document Range Of Scientific Experiments About Cannabis In 2022, NORML Assessment Displays

    Photo courtesy of Brendan Cleak.

    Cannabis Minute is made achievable with guidance from viewers. If you depend on our cannabis advocacy journalism to stay educated, make sure you take into consideration a monthly Patreon pledge.

  • Cannabis For Pain Relief? Review of 20 Studies Provides Sobering Results : ScienceAlert

    Cannabis For Pain Relief? Review of 20 Studies Provides Sobering Results : ScienceAlert

    Hashish is a single of the most extensively applied medicines in the environment. Though there are only a several nations around the world where hashish is authorized for recreational use, a lot of much more nations have legalized the use of cannabis for clinical explanations.

    Decreasing ache is one particular of the most widespread causes people today report working with healthcare cannabis. According to a US national survey, 17 percent of respondents who experienced reported using cannabis in the previous yr had been approved clinical cannabis.

    When it comes to self-medicine, the quantities are even higher – with estimates that concerning 17-30 per cent of grown ups in North The us, Europe and Australia reporting they use it to regulate pain.

    Though hashish (and hashish-derived products and solutions, these types of as CBD) may possibly be greatly employed for minimizing ache, how productive it actually is in executing this is still unclear. This is what our recent systematic review and meta-analysis sought to uncover.

    Our review, revealed in the Journal of the American Professional medical Affiliation, indicates cannabis is no much better at relieving discomfort than a placebo.

    To carry out our research, we appeared at the results of randomized managed trials in which cannabis was in comparison with a placebo for the treatment of clinical pain. We especially provided reports that when compared the transform in agony depth before and after remedy. In whole, we looked at 20 scientific tests involving just about 1,500 men and women altogether.

    The experiments we integrated seemed at a wide range of different soreness circumstances (these as neuropathic discomfort, which is brought on by hurt to the nerves, and a number of sclerosis) and kinds of hashish goods – like THC, CBD and artificial hashish (these types of as nabilone). These solutions were being administered in a wide range of strategies, which includes by using pill, spray, oil and smoked.

    The majority of the study’s contributors were female (62 percent) and aged between 33 and 62. Most of the experiments were carried out in the US, Uk or Canada – nevertheless we also bundled studies from Brazil, Belgium, Germany, France, the Netherlands, Israel, the Czech Republic and Spain.

    Our meta-examination confirmed that agony was rated as currently being drastically fewer rigorous after treatment method with a placebo, with a reasonable to huge outcome depending on each and every person. Our workforce also noticed no substantial variation between cannabis and a placebo for minimizing discomfort.

    This corroborates the outcomes of a 2021 meta-evaluation. In simple fact, this 2021 meta-analysis also identified that larger-high-quality studies with greater blinding techniques (exactly where both individuals and scientists are unaware of who is getting the energetic compound) in fact had better placebo responses.

    This suggests that some placebo-managed cannabis trials fail to be certain suitable blinding, which may possibly have led to an overestimation of the effectiveness of medical hashish.

    Our examine also discovered a lot of individuals can distinguish among a placebo and active hashish, despite obtaining the exact odor, flavor and look. If they are informed that they are acquiring or not acquiring cannabinoids, they are a lot more possible to deliver a biased assessment of the usefulness of the intervention. So to make sure researchers are observing the true impact of cannabis, contributors won’t be able to know what they receive.

    Media coverage

    Our examine also examined the way the research ended up protected by the media and academic journals to see no matter if it connected to the therapeutic effect members reported. We did this simply because study has proven media coverage and details on the net can influence the anticipations that a man or woman has of a treatment method.

    Media existence was measured by way of Altmetric, which is a strategy of analyzing mentions of a review in the media, blogs and on social media. Academic effect was measured in terms of citations by other scientists. We observed a whole of 136 information things in the media and weblogs.

    We classified coverage as optimistic, negative or neutral relying on how the benefits ended up presenting about the usefulness of hashish for managing agony. The mind-boggling the vast majority of news merchandise documented that hashish experienced a constructive result for treating agony. This indicates that media coverage to hashish tends to be constructive, irrespective of what a study’s outcomes truly have been.

    There are a lot of illustrations of the connection concerning therapy anticipations and placebo responses. If a person thinks they will encounter aid from their suffering by employing a certain item or treatment method, this can change the way they conclude up perceiving incoming agony alerts – making them imagine their agony is considerably less critical. Recent evidence suggests that the placebo outcome may perhaps operate even if we’re offered with proof that contradicts our preliminary expectations.

    We are unable to say with 100 {fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} certainty that media protection is dependable for the high placebo response observed in our overview. But given placebos have been demonstrated to be just as very good as hashish for handling ache, our benefits clearly show just how critical it is to feel about the placebo effect and how it can be motivated by exterior components – these kinds of as media protection.

    For solutions, these kinds of as cannabinoids, that obtain a good deal of media focus, we need to have to be more arduous in our clinical trials.The Conversation

    Filip Gedin, Postdoctoral Researcher, Ache investigation, Karolinska Institutet.

    This posting is republished from The Discussion beneath a Artistic Commons license. Read through the unique article.

  • Beyerdynamic Free Byrd earbud review

    Beyerdynamic Free Byrd earbud review

    Beyerdynamic has long been a household name in the audiophile world, best known for its popular, premium over-ear headphones. So what happens when the company distills its signature sound prowess into a pair of true wireless earbuds? You get the Free Byrd: A $249 pair of buds with dependable active noise cancellation, superb battery life and excellent sound that’s worthy of the Beyerdynamic name.

    But while Beyerdynamic’s first-ever true wireless earbuds have a lot going for them, they’re held back by frustrating controls and a bulky design that might not be for everyone. Before you make the big $249 splurge, here’s what I think after nearly a month of using these buds during work, play, travel and everything in-between.

    A great pick for audiophiles who are willing to splurge, the Beyerdynamic Free Byrd offer some of the best sound quality and battery life you can find in a pair of premium earbuds. However, those turned off by their bulky design and inconsistent touch controls should look at the Sony WF-1000XM4 or cheaper options like the AirPods Pro.

    Mike Andronico/CNN

    The second I opened the box, I could see how the Beyerdynamic Free Byrd set themselves apart from any other pair of wireless earbuds I’ve tested. That’s because these buds ship with a whopping 8 pairs of ear tips — that includes five silicone tips ranging from extra small to extra large, as well as foam options in small, medium and large for those who need something more sweat-friendly while working out.

    That’s an unheard of level of physical customization — most buds include three or four sets of tips — and for folks that usually have a hard time finding the right fit (or want to be able to swap out ear tips once they get sweaty), could make the Free Byrd worth the price of admission alone. Once I settled on the standard large tips, I was treated to a lightweight, secure fit that made it easy to completely forget I was wearing the buds during long bouts of working, walking and traveling. Well, until I looked in the mirror or tried to lay down, but more on that later.

    Mike Andronico/CNN Underscored

    On top of feeling great in-ear, the Free Byrd are some of the longest-lasting earbuds I’ve ever used. I got through close to a whole week of listening without even having to charge the case, and that’s including long work hours, train rides, dog walks and even a few flights — all with active noise cancellation activated most of the time. I was truly staggered by the Free Byrd’s endurance, as even some of my favorite buds (including the Beats Fit Pro and Sony LinkBuds S) required me to plug in the case after three or four days of regular use.

    Beyerdynamic’s buds alone are rated for up to 11 hours of runtime, with an additional 19 hours from the case, and my testing lines up with that — if not exceeds it. That puts them roughly in line with the 12 hours and 30 minutes we got from the similarly high-end Sony WF-1000XM4 (our current best noise-canceling earbuds pick), and well ahead of the 5 hours and 30 minutes we eked out of the Bose QuietComfort buds.

    Great, customizable audio and strong noise cancellation

    Mike Andronico/CNN Underscored

    Beyerdynamic is one of the biggest names in the high-end audio space, so it’s no surprise that their first true wireless earbuds sound great. The crunchy guitars, rollicking bass and snappy drums of my favorite punk songs all sounded bright and loud without overpowering one another, and I could clearly make out the dueling vocal harmonies in Phoebe Bridgers’ ethereal electronic ballad “Sidelines.” I was happy to use the Free Byrd as my main music headphones for close to a month, and found them to offer fuller overall sound and deeper bass than the more mainstream buds I usually use like the Beats Fit Pro and LinkBuds S.

    I found the Free Byrd to sound fantastic out of the box, but you can tweak them to your liking using the MIY companion app for iOS or Android.  The app lets you create a personalized sound profile by completing a quick audio test, which consists of a few minutes of holding a virtual button every time you hear a beep. Once the app has gauged your hearing style, you can use a slider to decide how much of your personalized profile you want to use versus the earbuds’ default settings. I didn’t notice a big difference in quality after doing this test, but it’s a nice extra for those with a super discerning ear.

    The MIY app also has a handful of sound presets, including bass boost for thumping low-end and a speech setting for amplifying voices during podcasts. These all work as advertised, though certain settings like “v-shape” and “brilliance” might not mean much to non-audiophiles. Either way, the Free Byrd offer excellent audio quality even before you make any tweaks, and these equalizer settings are there for folks who like tinkering. The app even lets you dig into stats such as your total time spent listening to music and taking calls, which was handy for writing this very review.

    A $249 pair of earbuds better have good active noise cancellation, and fortunately, that’s absolutely the case here. The Free Byrd did a good job dampening everything from my overworked air conditioner to the loud clangs of construction outside my apartment. I found Beyerdynamic’s ANC to be a bit stronger than Beats’, though Sony’s LinkBuds S were a little more suppressive than both when I tested them against my noisy New York street. The Free Byrd’s Transparency mode is likewise reliable, amplifying all of the aforementioned sounds when I needed to stay alert while walking my dog (though it also made her barking sound extra harsh). I just wish switching between the two modes was a little easier, but more on that later.

    Mike Andronico/CNN Underscored

    As great as the Free Byrd feel and sound, their unreliable touch controls are frustrating enough to make me want to switch to something else. While Beyerdynamic’s buds offer all of the requisite control options — such as pausing playback, skipping songs and adjusting volume — they’re stuck behind inconsistent touch inputs and a few odd gestures that you can’t customize. It often took multiple attempts for me to simply pause a song with a single tap, and double-tapping to switch between noise canceling and Transparency mode didn’t always work well either. And while each tap is met with an audible beep to let you know which control you’re about to activate, those sounds often got buried by my music.

    My other big issue is that some of the Free Byrd’s controls just don’t feel natural. I’ve grown accustomed to using one tap to pause playback and two taps to skip songs on most earbuds, but these buds use a strange, unintuitive pattern of pause/play (one tap), noise control (two taps) and skip song (three taps). This wouldn’t be as big a deal if you could customize the controls via the MIY companion app, but unfortunately, you cannot. Perhaps I’ve been spoiled by the accurate physical controls on my Beats earbuds, but even recent touch-based models such as the Sony LinkBuds S are far more reliable.

    Mike Andronico/CNN Underscored

    This may be a matter of personal preference, but I don’t find the Free Byrd to be very pleasing aesthetically. While some music fans may appreciate their guitar pick-inspired shape, these buds are some of the bulkiest I’ve ever seen. I don’t love the way their thick exterior juts out of my ears when I’m out and about, and even if you take my vanity out of the equation, their large design made them uncomfortable to wear when I used them to listen to some sleep sounds while laying down (to be fair, there are dedicated sleep headphones for that, like our top-rated Bose Sleepbuds 2). The Free Byrd buds aren’t unique in this regard — the Bose QuietComfort earbuds are similarly bulky but offer top-notch ANC in return — so you’ll have to weigh whether you care more about style or performance.

    The Free Byrd’s case also takes up a good amount of pocket space (and is extremely prone to smudges and scuffs), and while they’re comfortable to wear overall, each 2.1-ounce bud feels noticeably heavier than the Beats Fit Pro I typically use.

    Mike Andronico/CNN

    When it comes to sound quality, battery life and active noise cancellation, the Beyerdynamic Free Byrd are worth their hefty $249 price tag. They’re some of the best-sounding wireless earbuds you can buy, and they last longer than nearly all of the competition. Their handy companion app and plethora of swappable ear tips certainly don’t hurt either.

    However, the Free Byrd’s bulky design and unreliable touch controls hold them back from being the best wireless earbuds for my daily use. However, if you care more about great performance than having a stylish pair of buds in your ears, the Free Byrd could be an excellent fit for you — especially since they’re cheaper and longer-lasting than the similarly chunky Bose QuietComfort buds.

    But as compelling as a package as the Free Byrd are, I’d still point most people to alternatives like the AirPods Pro, Beats Fit Pro and LinkBuds S, which are sleeker, have more dependable controls, and are typically way cheaper. And if you do want to splurge, the $279 Sony WF-1000XM4 remain our premium ANC pick thanks to their deeper sound customization options and superior design.

  • Efficacy, Safety, and Regulation of Cannabidiol on Chronic Pain: A Systematic Review

    Efficacy, Safety, and Regulation of Cannabidiol on Chronic Pain: A Systematic Review

    According to Forbes, in October 2020, cannabidiol (CBD) sales in the United States reached $4.2 billion after the federal government legalized hemp-derived CBD in 2018 [1]. In addition, the World Health Organization (WHO) in 2019 re-classified CBD and <0.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of delta-9-tetrahydrocannabinol (THC) as not under international control and recognized its medical value in 2020 [2]. Hence, CBD is a rapidly expanding business expected to increase its value to $20 billion in 2025 [1].

    CBD is a nonintoxicating chemical ingredient from the Cannabis sativa plant [3]. CBD’s medical value was a hot topic for debate before being recognized in the medical field. One preparation of CBD approved by the U.S. Food and Drug Administration (FDA) is Epidiolex, an oral solution given to patients less than two years old to treat two rare and severe forms of seizure, Lennox-Gastaut syndrome and Dravet syndrome [4]. In addition, dronabinol [a synthetic delta-9-tetrahydrocannabinol (THC) product] and nabilone (like THC) were regulated by the FDA for the treatment of chemotherapy-induced nausea and vomiting [5]. Dronabinol is also used for AIDS-associated anorexia. With its federal legalization, CBD dispensaries continue to open one after another. People have more access to a wide variety of CBD products like cannabis flowers, tinctures, concentrates, topical lotion/creams, and edibles which are self-administered and with little or no supervision by a physician [6]. CBD oils provide relief for various conditions, including pain without intoxication [3]. Regulations of cannabis products remain a challenge for most countries.

    Chronic pain is a continuous or recurring pain for three months or longer experienced by a patient due to various causes. Different types of chronic pain are identified based on their nature, location, and characteristics. It is a significant cause of disability globally, and billions of dollars are spent annually to alleviate its outcomes [7]. While the opioid crisis increases, CBD’s role in pain management unveils as animal studies show promising evidence [8]. Further investigation and trials into CBD’s therapeutic value are ongoing due to its natural source, numerous usages, lower risk of addiction or dependency, and relative safety [7]. FDA regulation of CBD needs more clinical trials to determine its effectiveness and safety and should meet proper standards for authorization [9].

    This paper aims to answer the efficacy and safety of CBD in chronic pain using a systematic review of articles from five databases. This study will fill the existing gap and update knowledge on CBD’s role in chronic pain.

    Methods

    Protocol

    This descriptive systematic review was done according to the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 2020 checklist [10]. Before the search of the databases, a protocol was made and shared with the research team to analyze and finalize. The main question of the review: What is the efficacy and safety of CBD in adult patients with chronic pain? The PICO strategy was used to formulate the question of this review. The review protocol can be acquired with a request addressed to the lead author.

    Search Strategy

    PubMed, PubMed Central (PMC), Medline, Cochrane Library, and ScienceDirect were utilized as the major databases and search engines. In PubMed, the search was done using keywords and a medical subject heading (MeSH). The keywords “Cannabidiol” and “chronic pain” were applied to obtain related literature. The MeSH strategy used in PubMed and PMC were: (“Cannabidiol/adverse effects”[Majr] OR “Cannabidiol/isolation and purification”[Majr] OR “Cannabidiol/metabolism”[Majr] OR “Cannabidiol/pharmacokinetics”[Majr] OR “Cannabidiol/pharmacology”[Majr] OR “Cannabidiol/poisoning”[Majr] OR “Cannabidiol/therapeutic use”[Majr] OR “Cannabidiol/toxicity”[Majr]) AND (“Chronic Pain/drug therapy”[Mesh] OR “Chronic Pain/prevention and control”[Mesh] OR “Chronic Pain/therapy”[Mesh]). Booleans “AND” and “OR” were used.

    Additionally, keywords such as Cannabidiol, CBD, Hemp, Marijuana, Chronic Pain, and other synonyms were applied to the other databases. Furthermore, other publications in the reference list and related studies were also examined to see if they were relevant and could be included in this review.

    There were a total of 2298 articles extracted from all the databases. PubMed, PMC, and Medline have 289 articles. The Cochrane Library and Science Direct gave 73 and 1936 articles, respectively. The databases were last accessed on April 2022.

    Eligibility Criteria

    A PRISMA flow diagram 2020 was used to show the study’s inclusion and exclusion of articles found in the databases used. The inclusion criteria for eligibility were: (i) studies in an adult population >18 years old; (ii) patients with pain symptoms of less than three months duration; (iii) all available preparations of CBD; (iv) human studies only; (v) publication in English; and (vi) publication in the last five years. Studies with pediatric patients, acute pain, and animal studies were excluded. Studies with no available full text were also excluded from the review.

    Data Collection Process: Synthesis, Extraction, and Management

    All titles of the articles initially obtained from databases were selected by applying the eligibility criteria set. Duplicates were eliminated. The titles were read, and unrelated articles were excluded. The abstracts of the remaining articles were further screened for relevance. The full text of the publications left was obtained, and those without full text were excluded.

    Quality Assessment in Included Studies

    The Scale for the Assessment of Narrative Review Articles (SANRA) [11], Assessment of Multiple Systematic Reviews (AMSTAR) [12], JBI tool for Case Reposts [13], New Castle Ottawa [14], and Risk of Bias 2 [15] in the Cochrane Risk Assessment Tool (RoB 2) were used to identify the eligible articles based on the kind of study for each publication. Two co-authors (NJ and NV) assessed the eligibility of the articles.

    Results

    Search Results

    Five databases (PubMed, PubMed Central, Medline, Cochrane Library, and ScienceDirect) were used to identify publications included in the review. Figure 1 is a PRISMA 2020 flow diagram showing how related studies included in the review were identified [10].

    Using MeSH and keywords like cannabidiol, CBD, hemp, and chronic pain, 2298 publications were obtained. PubMed, PMC, and Medline have 289 publications. The Cochrane Library and Science Direct listed 73 and 1936 publications, respectively. A preliminary screening was done. Upon checking for duplicates, 22 publications were excluded. Filters were applied using the exclusion and inclusion criteria to exclude 1704 publications. Other reasons include manual screening and protocol articles that eliminated 523 publications. Abstracts were screened, and 25 publications out of 49 were excluded. Fifteen full papers were retrieved, while nine were not. Two do not have full texts, and one is an animal study, hence excluded. The remaining publications were assessed for eligibility using the appropriate assessment tool. A total of 12 studies were found eligible for this review.

    Results of Quality Appraisal

    A summary of the studies and the quality appraisal tool used for each one is shown in Table 1.

    Kind of study Quality assessment tool Number of articles
    Review  SANRA 5
    Systematic review AMSTAR 3
    Case report JBI tool 1
    Observational New Castle Ottawa 2
    Randomized controlled trial Cochrane Bias Assessment tool (RoB 2) 1

    The study must get a 70{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to be eligible for this review. Detailed quality appraisals with the corresponding tools used for each study are shown below. Table 2 shows the use of SANRA for five review articles.

    Publication Boyagi et al. [8] Mauer et al. [5] VanDolah et al. [3] Mücke et al. [16] Fisher et al. [17]
    Justification of the article’s importance in the readership 2 2 2 2 2
    Statement of concrete aims or formulation of questions 1 1 1 2 1
    Description of the literature search 2 2 2 2 2
    Referencing 2 2 2 2 2
    Scientific reasoning 2 2 2 2 2
    Appropriate presentation of data 1 2 2 2 2

    AMSTAR is utilized to assess the eligibility of three systematic reviews shown in Table 3.

    Publication Rabgay et al.[18] Pagano et al. [19] Scuteri et al. [20]
    Did the research questions and inclusion criteria for the review include the components of PICO? Y Y Y
    Did the report of the review contain an explicit statement that the review methods were established prior to the conduct of the review, and did the report justify any significant deviations from the protocol? Unclear Unclear Unclear
    Did the review authors explain their selection of the study designs for inclusion in the review? Y Y Y
    Did the review authors use a comprehensive literature search strategy? Y Y Y
    Did the review authors perform study selection in duplicate? Y Y Y
    Did the review authors provide a list of excluded studies and justify the exclusions? Unclear Unclear Unclear
    Did the review authors describe the included studies in adequate detail? Y Y Y
    Did the review authors use a satisfactory technique for assessing the risk of bias (RoB) in individual studies that were included in the review?  Y Y Y
    Did the review authors report on the sources of funding for the studies included in the review? Y Y Y
    Did the review authors account for RoB in individual studies when interpreting/discussing the results of the review? Unclear Y y
    Did the review authors provide a satisfactory explanation for, and discussion of, any heterogeneity observed in the results of the review? Y Y Y

    Table 4 illustrates JBI as a quality assessment tool for case reports.

    Publication Diaz et.al. [21]
    Demographic characteristics Y
    History and timeline Y
    Presentation of clinical condition Y
    Diagnostic test and results Y
    Intervention and treatment Y
    Post-intervention clinical condition Y
    Adverse events N
    Take-away lessons Y

    New Castle Ottawa Tool is used to evaluate the eligibility of two observational studies in Table 5.

    Publication Capano et.al. [7] Boehnke et.al. [6]
    Representativeness of the exposed cohort * *
    Selection of the non-exposed cohort    
    Ascertainment of exposure * *
    Demonstration that outcome of interest was not present at start of study * *
    Comparability of cohorts on the basis of the design or analysis * *
    Assessment of outcome * *
    Adequacy of follow up of cohorts * *

    The RoB 2 tool is a revised Cochrane RoB employed for RCT assessment as shown in Table 6.

    Publication Lichtman et al. [22]
    Randomization process Low
    Deviations from the intended interventions (effect of assignment to intervention) Low
    Missing outcome data Low
    Measurement of the outcome Low
    Selection of the reported result Low
    Overall risk of bias  Low

    Data Extraction

    A total of 12 publications were found eligible for this systematic review. Each article included in this review was read and scrutinized. Relevant information was summarized in Table 7 to show an overview of each study collected from the databases.

    Author and year of publication Purpose of the study Number of patients/studies Type of study Main findings
    Boyaji et al. [8] To find an alternative treatment that is safer and more effective than opioids to combat chronic pain challenges. 7 studies Review Cannabidiol is a promising alternative to manage pain but hard to make recommendations due to the difficulty of attributing the therapeutic properties to CBD alone.
    Fischer et al. [17] To identify new scientific advances to make an updated ‘Lower Risk Cannabis Use Guideline’ (LRCUG).  Not specified Review The high-risk group (early adolescent, patient with comorbidity, and pregnant or breastfeeding women) can have a harmful outcome from CBD use; hence, lowering the risk factor can also lessen the adverse outcome.
    Mauer et al. [5] To know the safety, efficacy, and adverse effect of cannabis-based products on athletes. 2224 patients Review Recommendations from physicians are promising but hard to do since studies available are from non-athletic subjects.
    VanDolah et al. [3] To identify a non-intoxicating alternative to opioids in chronic pain management. 102 studies Review CBD and hemp oil have a positive potential benefit in managing chronic pain, and more research is required.
    Mücke et al. [16] To compare if cannabis-based medication versus placebo or conventional drugs are safe, efficient, and tolerable. 16 studies, 1750 patients Review Some patients with neuropathic pain may benefit from cannabis-based medicine (3rd or 4th line therapy), and no high-quality evidence to show how efficacious cannabis-based drugs are.
    Pagano et al. [19] To evaluate the safety level, dosing, and timing of CBD on healthy cells. 29 studies Systemic review Dose-dependent inhibition of cell viability above two micrograms while apoptosis is observed in 10 micrograms CBD. Anti-inflammatory effects and decreased ROS production were also noted.
    Rabgay et al. [18] To determine the role of the route of administration of cannabis and cannabinoids on pain and its side effects. 25 studies, 2270 patient Systemic review Among different routes of administration of THC/CBD, the Oro-mucosal route was dominant in controlling pain from different causes like cancer, neuropathic, and nociceptive pain.
    Scuteri et al. [20] To know the efficacy of cannabinoid-based products in ocular pain regimens. 4 studies Systemic review Preclinical studies are needed to establish the efficacy of CBD in ocular inflammation and neuropathic pain, although analgesia is observed using CBD oil. It is noted that the is analgesia as well on the topical formulation.
    Diaz et al. [21] To describe a patient with chronic pressure injury treated with medical cannabis oil (THC and CBD) for pain relief and sleep improvement. 1 patient Case report Medical Cannabis oil containing THC and CBD taken orally improves pain and sleep with direct or indirect effect on wound healing.
    Boehnke et al. [6] To describe naturalistic cannabis use routine and its benefits. 1087 patients Observational (cross-sectional) The risk and benefits of medical cannabis can be further observed when administration route profiles are used to make subgroups.
    Capano et al. [7] To determine the effect of CBD (full hemp extract) on chronic pain regarding the quality of life and opioid use. 131 patients Observational (prospective cohort) CBD improves pain, quality of life and sleep quality and decreases opioid use in patients who have chronic pain on narcotics.
    Lichtman et al. [22] To assess the use of nabiximols as an adjunct to opioids in advanced cancer patients with poorly controlled pain. 397 patients RCT Advanced cancer patients on lower opioid therapy with early intolerance to opioid may benefit more from CBD as adjunct medication, although CBD is not superior to placebo on primary efficacy.

    Discussion

    CBD is a fast-growing business following its federal legalization in 2018. With this, more people have gained access to CBD, especially those with chronic pain on pain medications, and have experienced promising outcomes. Hence, more research and studies are being done to give patients with chronic pain an efficacious and safe alternative to the existing kinds of pain medication available on the market.

    Cannabidiol versus Tetrahydrocannabinol

    The Cannabis sativa plant has many strains, but the more popular ones are marijuana and hemp. Phytocannabinoids can be extracted from the cannabis plant, and this active chemical, when combined with the receptor, affects the functioning of the body in many ways. THC and CBD are famous examples of these phytocannabinoids obtained from marijuana and hemp, respectively. THC attaches to cannabinoid receptor 1 (CB1) while CBD attaches to several receptors like CB receptors, transient receptor potential vanilloid 1, G protein-coupled receptor 55, and serotonin 5-HT1A [3]. CBD and THC have the same molecular formula, C21H30O2, and an almost identical molecular mass of 314.464 g/mol and 314.469 g/mol, respectively [23]. Figure 2 illustrates the structural formulas of CBD and THC, highlighting a vital difference between the two: a cyclic ring for THC and a hydroxyl group for CBD.

    This difference makes THC a potential partial agonist to the CB1 receptor and CBD a negative allosteric modulator, on the other hand [23]. The stimulation of CB1 receptors produces the psychotropic effects experienced with THC consumption but is not evident in CBD use. Metabolism is by the cytochrome P450 superfamily; hence many drug interactions are possible.

    In a review done by VanDolah et al., more studies focused on the benefits of prescribed THC drugs; on the other hand, four studies were linked to CBD’s potential therapeutic actions, safety, and adverse effects [3]. Some of the potential therapeutic actions of CBD include relief of chronic pain, sleep disorders, spasticity and Tourette syndrome, nausea and vomiting in chemotherapy, and weight gain in HIV patients, to name a few. Its adverse effects include liver toxicity, somnolence, decreased appetite, diarrhea, and low blood pressure [3]. In addition, Scuteri et al., a systematic review of four studies, revealed that CB2 agonist HU308 alleviates inflammation in the eyes by reducing uveitis-induced leukocyte adhesion and lipidome profile changes [20]. It also highlights the antinociceptive and anti-inflammatory effects of D8-THC, cannabidiol, derivative HU308, and the new racemic CB1 allosteric ligand [20]. Another study with 2224 patients by Maurer et al. revealed that the patients’ post-injury three and four-week use of cannabis after concussions resulted in a lower severity score but not faster recovery from concussion symptoms [5]. The case report of Diaz et al. on a patient with pressure injury exhibiting pain and sleep problems was given with three different medical cannabis oils (1 CBD-dominant and 2 THC-dominant) in increasing doses and revealed an improvement in sleep quality with a decrease in pain and anxiety [21]. An incidental wound improvement was noticed starting at two weeks post-treatment [21]. These studies highlighted different benefits of CBD on different areas of the body, making the potential value of the CBD product even greater. The studies complement each other in strengthening the value of CBD medically when used on different body parts.

    Regulation on Cannabis

    In the 2014 Agricultural Act, hemp and marijuana differences are notable, defining the legality of “industrial hemp” (Cannabis sativa L.) and any parts of the plant (with THC content <0.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} dry weight) for research purposes [3]. The use of medical cannabis is permitted in 37 states, four territories, and the District of Columbia and is prohibited in three states and one territory [24]. Figure 3 shows a clear picture of the regulation of cannabis per state in the United States.

    With more states opening their doors to the medical benefit of CBD, the issue of obtaining good quality CBD poses a risk for those who want to use it as an alternative to their current pain medications [25]. There is a high price tag on good quality CBD available, and affordable CBD products are not 100{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} reliable due to some manufacturers’ mislabeling issues about their exact content. In addition, the FDA still cannot impose strict regulations because CBD is not considered a pharmaceutical agent anymore [9].

    Efficacy and Safety of CBD

    In comparison to THC, CBD is a relatively new drug, and studies are limited to establishing its safety and efficacy. Moreover, the regulations surrounding the use of CBD are still highly debatable. In a systematic review of 229 studies done by Pagano et al., the effects of CBD on healthy cell characteristics such as cell viability, cell proliferation, wound repopulation, apoptosis, and cell cycle were tackled [19]. Dose-dependent administration showed a significant reduction of cell viability (above 2 mM); oral cells are inhibited at 10 mM, while cell proliferation inhibition is evident in all doses used (2, 6, and 10 mM). Cell migration decreased after giving 10 mM for 24 hours [19]. However, there was no significant change at 6 mM. Lastly, an increase in apoptosis is observed at 10 mM [19]. These observations show that a variable amount of CBD exerts different effects on a healthy cell. The dosage mainly dictates the extent of the results. It can be noted that a higher dose means more inhibition of cell processes but more stimulation of apoptosis.

    Furthermore, Rabgay et al. conducted a systematic review of 25 studies with 2270 patients regarding the different dosages and routes of administration for CBD [18]. They found out that cannabis and cannabinoids act on different types of pain depending on the dosage and route of administration. A low dose for pain relief was used for all studies reviewed and exhibited an average dose of 19.82 mg/day [18]. Furthermore, they discovered that the difference in the dosage administered elicited relief in different pain types, such as neuropathic pain, which is 23.56 mg/day, cancer pain, which is 19.69 mg/day, and nociceptive pain, which is 13.75 mg/day [18]. In addition, different routes of administration showed other forms of pain relief. The oromucosal route is THC/CBD and THC for neuropathic and cancer pain; the oral route is THC for cancer pain; and the inhalation of standardized cannabis with THC (SCT) for neuropathic and oral standardized cannabis extract with THC (SCET) for nociceptive pain [18]. Rabgay et al. concluded that there is no sufficient evidence to fully establish CBD’s efficacy on pain. In a review done by Boyaji et al. on seven studies using nabiximols (CBD+THC) spray as a medication for pain, four RCT studies concluded a positive effect on their pain while on nabiximols spray compared to placebo [8]. While Rabgay concluded that the evidence is insufficient to determine CBD’s efficacy in pain, Boyaji found it challenging to recommend CBD’s use in chronic pain. Access to pure CBD alone is the main reason for these conclusions.

    Some studies showed promising evidence to support the safety of CBD. A review of 16 RCTs conducted by Mücke et al. in 1750 adult participants with neuropathic pain showed that cannabis-based medicine might help achieve >50{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} pain relief (primary outcome) compared with placebo [16]. It also increases nervous system adverse reactions, including psychiatric disorders, in 17{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of participants [16]. In addition, Fisher et al., in their review, made a recommendation to delay the use of cannabis until adolescence, avoid highly potent and widespread use, and prevent smoking cannabis from reducing its adverse effects like cardiovascular, physical, neurocognitive, psychosis, and mental problems [17]. In comparison, it can be deduced that proper dosage and route of administration are essential to gain the maximum effect from CBD use. CBD for pain relief still has a long way to be fully established, but the majority of studies possess promising outcomes. Therefore, formulation of the safety standard used for CBD could be a possibility soon if the growing evidence from more studies points to the efficiency and safety of CBD. Weighing the benefit versus the risk, backed by evidence, is a crucial step. The outcome of each study mentioned above can set a new playing field for pharmaceutical companies for drug development to explore and investigate using clinical trials in a large sample population.

    Chronic pain is persistent pain for more than or equal to three months in duration. It has been a complex issue, especially with its variable causes, the complexity of the associated symptoms, and opioid dependence [26]. Scientists and researchers are looking for alternative means to address chronic pain using more substantial evidence from clinical trials and observational studies. In an RCT done by Lichtman et al., nabiximols (THC+CBD) oromucosal spray was used as an adjunct treatment in 291 patients with advanced cancer and chronic pain on opioids [22]. The primary endpoint is the improvement of the average pain Numerical Rating Score (NRS) from baseline. NRS is calculated as the median difference between groups, which showed a positive value of 3.41{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (95{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} CI: 0.00{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}-8.16{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}; p=0.0854) in favor of the nabiximols group. No statistical significance was noted in the primary outcome [22]. However, there is improvement in other aspects such as Subject Global Impression of Change (SGIC), Physician Global Impression of Change (PGIC), and Patient Satisfactory Questionnaire (PSQ) from nabiximols compared to the placebo group [22]. Clinical improvement was noticed in the nabiximols group, though not statistically significant.

    On the other hand, Capano et al. did a prospective cohort study (with 97 participants) about the effect of CBD hemp extract on patients with chronic pain taking opioid medication [7]. The primary outcome showed that at week 8, 50 out of 94 (53.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) had decreased their opioid medications [7]. The secondary outcome reported that 89 (94{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) improved quality of life as measured by pain and sleep-related open-ended questions. In a similar cross-sectional survey with 1087 patients, Boehnke et al. determined the relationship between the route of administration, CBD content, and timing of use in managing chronic pain [6]. It was noted that the younger population uses inhalation while older people prefer the non-inhalational route. The mixed (inhalation + non-inhalation) route is preferred (45{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of respondents), and this is attributed to the tailored pain relief experienced [6]. The content of CBD and timing of use showed that CBD with sedation effects (Indicas) is usually taken at night. Boehnke et al. reiterated in this study that subgroups in the sample population are essential in analyzing the results of CBD use [6]. These two observational studies mentioned above hold decent evidence of the positive effect of CBD on chronic pain, like reduced opioid intake and improved sleep. However, there is a challenge for patients to report the actual outcome observed because health insurance covers opioid medication but not CBD. Therefore, there is fear on the patients’ part about CBD’s availability after research and the financial cost they would have.

    Management of chronic pain poses many challenges. With the crisis of opioid use and dependence, medical providers and the government need to work hand in hand to urgently find alternatives to the treatment of chronic pain, whatever the reason may be [27]. More studies and research are rolling in to provide evidence-based solutions to the current crisis. However, more minor studies are focused on using pure CBD products, which are nonintoxicating. As this systematic review proceeded, challenges and questions about CBD use in chronic pain were revealed. More published reviews and studies show promising results for the effect of CBD on pain relief, yet there is difficulty in making any recommendations. Regulations and categories of CBD need to be updated to make clinical trials easier. When evidence of CBD’s pain relief is fully recognized, guidelines need to be applied to the health insurance business to lessen its financial burden on the patient. An opioid is covered by most insurance, while CBD is not. In addition, good-quality and affordable CBD products should be available once everything is in place.

    Limitations

    A systematic review of the efficacy and safety of pure CBD products was initially planned, but there are limited studies and articles available. Clinical trials on CBD are also scarce because it is relatively new and obtaining a good quality product is still a problem. In addition, it was difficult to find studies that focused on CBD alone since THC is often mixed with it. Access to free full-text papers is constrained as some good-titled articles need payment to gain access. The language of the publication is also limited to English. Although the business of medical marijuana and CBD dispensaries is old, most countries worldwide are still regulating it to make it legal. Hence, there is a limitation in conducting studies on CBD products.